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Abstract 
Physical properties of bulk solids are typically governed by the molecular arrangement of 
individual building blocks with respect to each other in the crystal lattice. Thus the ability to 
synthesize molecular crystals with pre-organized connectivities allows for the rational design of 
functional solids with desirable and tunable physical properties. A thorough understanding of the 
various intermolecular interactions that govern the solid-state architectures is an important pre-
requisite for the rational design of molecular solids. 
In order to understand the role of molecular geometric complementarity in the design of 
solid-state architectures, we explored the structural landscape of two isomeric pyridine based 
acceptors (3N and 4N) with binding sites oriented along different directions, i.e. parallel and at 
angle of 60° respectively, with a series of even chain diacid (colinear binding sites) and odd 
chain diacid (binding sites oriented along 120°) using co-crystallization technique. The results 
obtained shows a striking correlation between the observed solid state architecture and geometric 
complementarity of interacting species. Combinations of 3N with odd and 4N with even chain 
diacid produced 1-D chains whereas 3N with even and 4N with odd chain diacid generated 0-D 
ring architectures. 
In order to exploit the possibility of fine-tuning physical properties using co-
crystallization techniques, solubility measurements were performed on 3N and 4N co-crystals 
with the diacids. The results show that the solubilities of 3N and 4N in the co-crystal form were 
very different from their solubility in the pure form. Also, there was a strong correlation 
observed between the solubility of the co-crystals and their corresponding co-formers, i.e. 
diacids. 
To explore the dependence of crystal structure on a physical property such as melting 
point, we synthesized co-crystals of 3,3‟-azopyridine and 4,4‟-azopyridine with a series of even 
chain diacids. Structural consistency was obtained within the two groups of co-crystals. In both 
groups, 1-D chains were formed with the diacid as the primary building block. However, In the 
series of 3,3‟-azopyridine co-crystals, the co-crystal with succinic acid showed a different solid-
state  packing arrangement (although the primary building block was same as others) compared 
to the others in the same series. This difference is also reflected as a deviation in the melting 
point, while the others in the series showed a perfect correlation between the structural 
  
consistency and melting point behavior. It was also observed that the co-crystals of 4,4‟-
azopyridine displayed higher melting points than co-crystals of 3,3‟-azopyridine which could be 
due to the differences in the overall packing of the crystal which is a combination of different 
intermolecular interactions that exist between molecules in the solid state. 
Using bi-functional donors (with both hydrogen and halogen bond donors on same 
backbone), we investigated the relative strengths of hydrogen and halogen bond donors in the 
presence of two isomeric acceptors, 3,3‟-azopyridine and 4,4‟-azopyridine, which exhibit 
geometric bias in their binding-site orientation. Based on the crystal structures, we noticed a 
preferential binding of hydrogen bond donors with 3,3‟-azopyridine and both hydrogen and 
halogen bond donors with 4,4‟-azopyridine. This shows that the two types of donors are very 
comparable and their binding preference is governed by the geometric complementarity between 
the donor-acceptor pair. 
Finally, we explored the scope of using co-crystallization for tuning the physical 
properties of two agrochemicals, cyprodinil and terbuthylazine. The crystal structures of the 
actives with a series of even chain diacids displayed structural consistency in the primary motifs 
within the two groups, while few differences were observed in the packing arrangement and 
secondary interactions. By forming co-crystals we were able to improve the solubility and 
melting point of cyprodinil, while ensuring that the hygroscopicity of the active was unaltered.   
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Abstract 
Physical properties of bulk solids are typically governed by the molecular arrangement of 
individual building blocks with respect to each other in the crystal lattice. Thus the ability to 
synthesize molecular crystals with pre-organized connectivities allows for the rational design of 
functional solids with desirable and tunable physical properties. A thorough understanding of the 
various intermolecular interactions that govern the solid-state architectures is an important pre-
requisite for the rational design of molecular solids. 
In order to understand the role of molecular geometric complementarity in the design of 
solid-state architectures, we explored the structural landscape of two isomeric pyridine based 
acceptors (3N and 4N) with binding sites oriented along different directions, i.e. parallel and at 
angle of 60° respectively, with a series of even chain diacid (colinear binding sites) and odd 
chain diacid (binding sites oriented along 120°) using co-crystallization technique. The results 
obtained shows a striking correlation between the observed solid state architecture and geometric 
complementarity of interacting species. Combinations of 3N with odd and 4N with even chain 
diacid produced 1-D chains whereas 3N with even and 4N with odd chain diacid generated 0-D 
ring architectures. 
In order to exploit the possibility of fine-tuning physical properties using co-
crystallization techniques, solubility measurements were performed on 3N and 4N co-crystals 
with the diacids. The results show that the solubilities of 3N and 4N in the co-crystal form were 
very different from their solubility in the pure form. Also, there was a strong correlation 
observed between the solubility of the co-crystals and their corresponding co-formers, i.e. 
diacids. 
To explore the dependence of crystal structure on a physical property such as melting 
point, we synthesized co-crystals of 3,3‟-azopyridine and 4,4‟-azopyridine with a series of even 
chain diacids. Structural consistency was obtained within the two groups of co-crystals. In both 
groups, 1-D chains were formed with the diacid as the primary building block. However, In the 
series of 3,3‟-azopyridine co-crystals, the co-crystal with succinic acid showed a different solid-
state  packing arrangement (although the primary building block was same as others) compared 
to the others in the same series. This difference is also reflected as a deviation in the melting 
point, while the others in the series showed a perfect correlation between the structural 
  
consistency and melting point behavior. It was also observed that the co-crystals of 4,4‟-
azopyridine displayed higher melting points than co-crystals of 3,3‟-azopyridine which could be 
due to the differences in the overall packing of the crystal which is a combination of different 
intermolecular interactions that exist between molecules in the solid state. 
Using bi-functional donors (with both hydrogen and halogen bond donors on same 
backbone), we investigated the relative strengths of hydrogen and halogen bond donors in the 
presence of two isomeric acceptors, 3,3‟-azopyridine and 4,4‟-azopyridine, which exhibit 
geometric bias in their binding-site orientation. Based on the crystal structures, we noticed a 
preferential binding of hydrogen bond donors with 3,3‟-azopyridine and both hydrogen and 
halogen bond donors with 4,4‟-azopyridine. This shows that the two types of donors are very 
comparable and their binding preference is governed by the geometric complementarity between 
the donor-acceptor pair. 
Finally, we explored the scope of using co-crystallization for tuning the physical 
properties of two agrochemicals, cyprodinil and terbuthylazine. The crystal structures of the 
actives with a series of even chain diacids displayed structural consistency in the primary motifs 
within the two groups, while few differences were observed in the packing arrangement and 
secondary interactions. By forming co-crystals we were able to improve the solubility and 
melting point of cyprodinil, while ensuring that the hygroscopicity of the active was unaltered.   
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Chapter-1 Introduction 
 1.1 Molecular chemistry vs supramolecular chemistry 
Molecular chemistry is a science based on covalent bonds. In a typical chemical 
synthesis, reactants undergo modifications that involve covalent bond breaking and bond 
formation on the road towards the desired final product often along with, some undesirable 
byproducts. These reactions are often multi-step processes that frequently require high-
temperature conditions, catalysts, solvents, isolation of intermediates and purification by 
chromatography. The concept of synthetic chemistry began with Wöhlers synthesis of urea in 
1828
1
, and since then, scientists have developed synthetic routes and techniques in order to 
synthesize large and complex natural products.
2
 
Supramolecular chemistry is defined as „the chemistry of molecular assemblies and of the 
intermolecular bond‟, by Jean-Marie Lehn, who won the Nobel Prize in 1987 for his outstanding 
contributions to the field.
3
 The origin of supramolecular chemistry can be traced back to the use 
of crown ethers and cryptands in binding of alkali metals.
4
 Recently it has gained global 
importance due to its wide array of applications in sensing
5
, anion recognition
6
, catalysis
7
, 
biomimetic materials
8
, porous materials
9
 and pharmaceutics.
10
 Supramolecular chemistry is 
concerned with how molecules recognize and communicate with each other using non-covalent 
interactions such as hydrogen bonds, halogen bonds, van der Waals forces
11, Π-Π interactions12 
and metal coordination
13
 (Table 1.1).
14
 Thus, unlike molecular chemistry that relies on covalent 
bonds in forming new products, supramolecular chemistry relies on reversible and relatively 
weak interactions for constructing multi-component assemblies (Table 1.1 and Fig 1.1). In 
addition, supramolecular synthesis is a one-pot method with no intermediates to isolate or no 
purification needed unlike covalent synthesis. 
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Table 1.1 Estimated strengths of intermolecular interactions
14, 7, 8
 
Type of interaction Strength (kJ/mol) 
Covalent 100-400 
Hydrogen bond 10-65 
Π-Π 0-50 
Metal-ligand 
Van der Waal 
0-400 
<5  
Halogen bond 5-180 
 
 
Figure 1.1 Covalent synthesis vs supramolecular synthesis 
 1.2 Crystal Engineering 
The term crystal engineering was coined by Schmidt in 1971, with reference to 
photodimerization of cinnamic acid in the solid state.
15
 Crystal engineering, a sub-section of 
supramolecular chemistry, is the rational design of molecular solids via intermolecular 
interactions to produce new functional solids with specific physical properties.
16
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 1.2.1 Molecular Recognition 
Molecular recognition is the key step towards building a multi-dimensional 
supramolecular framework.
17
 Molecules can be deliberately made to interact with each other and 
self-assemble under a given set of conditions. Every molecule has a unique set of features 
associated with its molecular structure, i.e. shape, geometry, chemical surface etc. When 
molecules (host and guest) are made to communicate, they selectively interact with a partner that 
has complementing features and form a supermolecule (Fig 1.2). Molecular recognition is thus 
selective binding with a purpose.
18
 
 
Figure 1.2 Molecular recognition 
 1.2.2 Co-crystallization vs recrystallization 
Co-crystallization is a tool for probing intermolecular interactions between molecules.
19
 
In a co-crystal, two or more distinctly different molecular entities are brought in close proximity 
and made to communicate via non-covalent interactions within the same crystal lattice. This is 
done without making or breaking any covalent bonds. The end result is the formation of a 
heteromeric species (co-crystallization) over homomeric species (a result of recrystallization), 
Fig 1.3. 
 
Figure 1.3 Schematic representation of co-crystallization and recrystallization processes 
4 
 
 1.2.3 Intermolecular interactions 
Molecular crystals are formed by periodic assembly of molecules connected via 
intermolecular interactions such as van der Waal interactions (sum of all attractive and repulsive 
interactions, dispersion interactions, close packing), hydrogen bonds (strong, moderate and 
weak) and halogen bonds.
20
 A crystal structure is the result of many intermolecular interactions 
of varying strengths, angles and directionalities. Apart from stronger interactions such as 
hydrogen and halogen bonds numerous weaker interactions exists in the crystal structure that 
significantly influence the overall crystal packing. Thus the resulting crystal is a balance between 
all the numerous strong and weak non-bonded interactions that co-exist between molecules. 
 1.2.3.1 Hydrogen bond  
The hydrogen bond is arguably the most widely used interaction for constructing 
supramolecular structures.
21
 A hydrogen-bond donor has a hydrogen atom (with partial positive 
charge) attached to an electronegative atom (D). It interacts with a hydrogen bond acceptor (A) 
which is an electron-withdrawing atom (with partial negative charge) forming D-H...A hydrogen 
bonds (Fig 1.4). The best example of hydrogen bonding can be found in nature, i.e. DNA, the 
molecule of life. The base pairs in DNA are connected using hydrogen bonds which are very 
selective and specific (Fig 1.5).
22
  
 
Figure 1.4 Schematic representation of a hydrogen bond 
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Figure 1.5 Representation of DNA (left) and hydrogen-bonded base pairs (right)
23
 
 
Hydrogen bond interactions are electrostatic in nature and directional (D-H···A angles 
tends to close to linear). They can be strong (N-H···O, O-H···O, N-H···N) or weak (C-H···O, C-
H···Π) depending on the electro negativities of the bonded atoms.20 Since in the solid state the 
energy of hydrogen bonds cannot be measured directly, computational studies provide us with 
various hydrogen bond energies that are calculated using high theory levels of calculation.
24
 
 1.2.3.1.1 Methods for detecting hydrogen bondings 
Often single crystal X-ray diffraction (SCXRD) is used to observe hydrogen-bonding 
interactions.
25
 This requires good quality crystals of reasonable size for diffraction purposes.  
Since growing single crystals is not always easy, SCXRD cannot always be relied on as the sole 
option to detect hydrogen bonding. Other characterization techniques like NMR and IR 
spectroscopy can also be used to detect the presence of hydrogen bonds in a given system. 
 1.2.3.1.1.1 1H NMR studies  
When a hydrogen atom interacts with an electronegative atom (acceptor), the hydrogen 
nuclues experiences a deshielding effect. This will result in a chemical shift of the nucleus 
towards higher frequencies, i.e. downfield shifted.
26
  For example, when a tripodal urea scaffold 
binds a terephthalate anion via N-H···O
-
 hydrogen‟s between the urea N-H protons and the O- of 
the carboxylate group, the interaction results in downfield shift of the N-H protons as seen in 
figure 1.6.
27
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Figure 1.6 a) Tripodal host molecule b) terephthalate anion guest and c) NMR spectrum of 
(a+b) indicating the downfield shift in the two N-H protons due to N-H...O hydrogen 
bonding interactions with the guest molecule
27 
1.2.3.1.1.2 IR spectroscopy 
IR spectroscopy is a very useful tool in the pharmaceutical industries to characterize 
different solid forms of the crystalline sample.
28
  IR spectroscopy can also be used as a powerful 
tool to detect hydrogen-bond interactions in different systems.
29
 A hydrogen bonded O-H···N 
interaction between a hydrogen bond donor and a heterocyclic nitrogen atom can be detected by 
the two broad stretches around 2450 and 1950 cm
-1
 region in the IR spectrum (Fig 1.7).
30
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Figure 1.7 IR spectrum of an oxime hydrogen bond donor (above) and a hydrogen bond 
formed between donor and bipyridine acceptor (below)
30 
 
 1.2.3.2 Halogen bonding 
Halogen bonds are non-covalent interactions between a covalently bound halogen atom 
and a Lewis base.
31
 In a covalently bonded halogen atom, i.e. C-X (X= F, Cl, Br or I) there exists 
a positive σ hole along the C-X bond axis farthest away from the carbon atom.20 This positive σ 
hole can interact electrostatically with electron pairs on Lewis bases. The equatorial zone of the 
halogen atom is polarized negatively. A covalently bonded halogen atom can thus interact 
electrostatically with both electronegative and electropositive species depending on the direction 
of approach (Fig 1.8).  
 
Figure 1.8 Region around covalently bonded halogen atom displaying positive and negative 
zone
20
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The strength of halogen bonding increases with an increase in the polarizability of the 
halogen atoms, i.e. F < Cl < Br < I, as can be seen from the MEP surface diagrams, when moving 
from F to I, the region of the positive σ hole increases (Fig 1.9).32 Just like hydrogen bonds (D-
H…A), halogen bonds (D-X…A where X= halogen) are directional and prefer linear interactions 
with acceptor sites.
33
 Halogen bonds have a wide range of applications in liquid crystals
34
, anion 
receptors
35
 and biological systems
36
. 
 
Figure 1.9
 
MEP surface diagram showing increasing hole 
CF4 < CF3Cl < CF3Br< CF3I
32 
 1.3 Potential applications of crystal engineering  
 1.3.1 The pharmaceutical sciences 
Chemists and engineers in the pharma industry seek to deliver the active ingredients in 
crystalline form to ensure optimum delivery, stability and purity. Currently there are several 
forms in which the active pharmaceutical ingredients (API‟s) occur such as salts, 
hydrates/solvates, polymorphs and co-crystals (Fig 1.10).
37
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             Figure 1.10 Schematic representation of the solid-state forms of API
37
 
 
During drug development, there are many problems encountered at different stages (Fig 
1.11).
38
 Crystal engineering can be used to solve some of the problems related to the 
bioavailability, i.e. solubility of the API by formulating different solid forms (co-crystals) of the 
drug that may have improved physico-chemical properties than the API component itself.
39
 
 
            Figure 1.11 Reasons for failure of drug compounds
39 
 1.3.2 The agrochemical sciences 
The term “agrochemical” refers to a collection of chemicals used for agricultural 
purposes such as pesticides, insecticides, herbicides and fungicides.
40
 Nearly 40% of the crop 
produced is inaccessible to humans due to loss by infestation (Fig 1.12).
41
 Agrochemicals are 
10 
 
therefore used to protect crops from pests and thus help improve the quality and quantity of crop 
production.  
 
Figure 1.12 Pie chart representing crop production
41
 
When used with caution, agrochemicals can promote better and increased crop 
production.
42
 However, they also pose serious health and environmental risks due to the 
contamination of soil and water reserves.
42
 The extent of environmental contamination is 
significantly influenced by the physical property of pesticides. Highly water soluble pesticides 
are likely to be run-off by running water and leached into the ground.
43
  
Physical properties such as solubility, hygroscopicity, thermal stability, filterability and 
flowability are influenced by the solid forms of materials. These properties affect the overall 
usability and efficacy of a given agrochemical. Designing different solid forms can affect these 
physical properties and make them more suitable for a particular form of application. Recently, 
co-crystals have been tested as an efficient alternative form for solid-state modification of the 
active ingredient.
44
 For example, 4-{[(6-chloropyrid-3-yl)methyl](2,2‟-difluroethyl)amino}furan-
2-(5H)-one is an active ingredient (AI) with insecticidal properties. Co-crystals of the AI with 
salicylic acid (1:1) has been synthesized which displays a higher melting point, 85 °C when 
compared to that of the active by itself (72-74 °C). Due to the increased thermal stability, the AI 
can be treated and handled at higher temperatures. The co-crystal also displays improved storage 
stability and solubility than the pure substance (Fig 1.13).
45
 
59% 
13% 
13% 
15% 
obtained by
production
loss by insects
loss by pathogens
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Figure 1.13 Structure of the insecticidal AI and co-former
45
  
 1.4 Goals of the thesis 
An improved knowledge of intermolecular interactions is critical for the design of 
molecular solids with pre-programmed connectivities. Since the molecular solid-state 
arrangement defines physical properties of bulk solids, a control of their architecture and 
assembly can make way for a reliable prediction and alteration of their bulk properties in a 
desirable manner.  
 
This dissertation will focus on five areas: 
 
1. Systematic study of intermolecular interactions and the resulting solid-state 
architectures in co-crystals of pyridine-amino pyridine based ligands 
The ligand of choice is a pyridine-amino/pyridine based molecule because these 
functionalities are found in a wide variety of pharmaceutically relevant compounds.
46
 
Systematically studying the binding preference of these functional groups in small molecules 
will provide us with an understanding of their behavior and binding pattern in larger and more 
complicated molecules. Two isomeric ligands will be synthesized and their interactions with a 
series of dicarboxylic acids will be studied using co-crystallization techniques. In addition, we 
will examine the extended architectures formed by different donor-acceptor combinations and 
elucidate structural trends. 
 
2. Using co-crystallizations to modulate physico-chemical properties of an API mimic 
In this section we will focus on altering the solubility of an API mimic in a systematic 
manner via co-crystallization with a series of FDA approved dicarboxylic acids. We will also 
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attempt to correlate the property of bulk solid with molecular properties (melting point and 
solubility) of its individual components. Finally, we will investigate the binding events of the co-
crystals in aqueous solution environment using isothermal titration calorimetry.  
 
3. Studying the interdependence of structure and physical property of molecular solids 
Two isomeric azopyridine molecules will be synthesized and its resulting supramolecular 
structure with a series of even-dicarboxylic acids will be systematically analyzed. The solid-state 
arrangement and a physical property like thermal behavior will be examined to establish for 
possible structure-property interdependence.  
 
4. Comparing hydrogen bond and halogen bond binding preferences as a function of 
geometric bias in the acceptor sites 
Since hydrogen and halogen bonds have properties that parallel each other,
47
 they are 
likely to be structurally competitive. In order to examine their competitiveness for an acceptor 
site, we will perform systematic co-crystallization experiments on a series of bi-functional 
donors (with both hydrogen and halogen bond donor on the same backbone) with two isomeric 
pyridine based acceptors. The study will establish the binding preference of the pyridine for 
hydrogen or halogen atom as a function of the geometric bias in the acceptor molecules. 
 
5. Application of crystal engineering in tailoring physical properties of an agrochemical 
compounds using co-crystallization technology 
We will use our knowledge of intermolecular interactions and co-crystallization to design 
new solid forms of an agrochemical pesticide (Cyprodinil and Terbuthylazine), investigate and 
modulate their physical properties as compared to the pesticide by itself. 
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Chapter-2 Establishing supramolecular control over solid-state 
architectures: A simple mix and match strategy 
 2.1 Introduction 
  Molecular self-assembly is at the core of supramolecular synthesis.  The 
knowledge of supramolecular synthons
1
 is a pre-requisite for the systematic design and assembly 
of molecular building blocks into predictable architectures. In crystal engineering
2
, robust 
heteromeric synthons like the acid...pyridine,
3
 acid...aminopyridine
4
 and hydroxy...pyridine
5
 are 
most commonly used to construct binary and ternary co-crystals via O-H···N hydrogen bonds
6
, 
Figure 2.1. 
 
Figure 2.1 Examples of supramolecular heterosynthons 
Hydrogen-bond interactions primarily depend on the chemical nature around the hydrogen atom, 
i.e. if it is part of an acid, hydroxy, oxime, amine etc, and on the electrostatic environment 
around it. The strength of a hydrogen bond typically ranges between 10–65 kJ/mol7. In 
supramolecular synthesis, the shape and dimensionality of the resulting assembly is governed by 
the geometric complementarity between the donor and acceptor units during the self-assembly 
process, Figure 2.2. A better understanding of the dependence of solid-state architecture on the 
geometric match between the building blocks can provide a path to more efficient design of 
reliable assemblies with controllable, pre-determined connectivities. 
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Figure 2.2 Examples of geometrically complementary building blocks forming assemblies 
of different dimensionalities 
In this study we sought to explore the link between the molecular geometry of the individual 
building blocks and the resulting structural outcome. Reliable and robust acid-pyridine/acid-
aminopyridine heterosynthons were used as the key interactions to lay a foundation for the 
construction of a supramolecular framework. We carried out systematic co-crystallization 
experiments between two ditopic pyridine based acceptors (N-(3-pyridin-2-yl) nicotinamide, 3N 
and N-(4-pyridin-2-yl) isonicotninamide, 4N) and a set of odd (malonic, glutaric, pimelic and 
azelaic) and even-chain (succinic, adipic,suberic and sebacic) di-carboxylic acid donors.  The 
acceptors differ in the relative orientation of the two binding sites (Fig 2.3); 3N has the binding 
sites positioned parallel with respect to each other, whereas in 4N they are at an angle of 
approximately 60° with respect to each other. Among the donors, odd-chain diacids have their 
two donor sites positioned at an angle of approximately 120° while in even-chain diacids, they 
are almost co-linear (Fig 2.4).  
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Figure 2.3 Binding site orientation in 3N and 4N 
 
 
Figure 2.4 Binding site orientation in even and odd-chain aliphatic diacids 
 
Depending upon the choice of the acceptor (3N or 4N) and donor (even or odd diacids) 
combination to form a co-crystal, there are four different assemblies that could potentially be 
formed, Figure 2.5.  
 
           Figure 2.5 Possible architectures from building blocks 3N and 4N 
     
Thus, the goals of this section are to; 
1. Synthesize the two acceptors, 3N and 4N. 
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2. Test the potential of 3N and 4N for forming co-crystals with odd and even-chain 
diacids. 
3. Grow single crystals, analyze them and elucidate any structural consistency. 
4. Determine the effect of molecular geometry of the interacting species on the 
resulting supramolecular architectures. 
 2.2 Experimental 
 2.2.1 Synthesis 
All chemicals, unless noted, were purchased from Sigma Aldrich and used without 
further purification.  Melting points were determined on a Fisher- Johns melting point apparatus. 
1
H and 
13
C NMR spectra were recorded on a Varian Unity plus 400 MHz or 200 MHz 
spectrometer in CDCl3 or D6-DMSO.  Infrared spectroscopy (IR) was done on a Nicolet 380 FT-
IR. 
 2.2.1.1 Synthesis of (N-(3-pyridin-2-yl) nicotinamide), 3N8 
The synthesis of 3N was carried out using a modified procedure.
8
 Nicotinic acid (1.45 g, 
11.79 mmol) and triethylamine (1.92 ml, 13.77 mmol) were dissolved in 20 mL of chloroform. 
Thionyl chloride (1.2 ml, 16.52 mmol) was added drop wise under a dinitrogen atmosphere 
maintaining the temperature between 5 and 10 °C. After the addition was complete, the mixture 
was heated under reflux for 3 h at the end of which a brown solution was obtained. The mixture 
was cooled to room temperature, then a solution of amino pyridine (1.29 g, 13.34 mmol), 
triethylamine (1.01 g, 10 mmol), and acetonitrile (20 mL) was added in situ and stirred at room 
temperature overnight. The organic layer was washed with water, and the solvent was removed, 
followed by column chromatography to yield an off-white powder as the product. Yield 35%, mp 
142−145 °C (lit. 141−143 °C).9 1H NMR (δH, 400 MHz, DMSO): 11.094 (s, N−H 1H), 9.135 (s, 
1H), 8.761 (d, 1H), 8.409 (d, 1H), 8.340 (d, 1H), 8.120 (d, 1H), 7.845 (t, 1H), 7.541 (t, 1H), 
7.189 (t, 1H). 
 2.2.1.2 Synthesis of (N-(4-pyridin-2-yl) isonicotninamide), 4N8 
The synthesis of 4N was carried out using a modified procedure.
8
 Isonicotinic acid (1.21 
g, 9.82 mmol) and triethylamine (1.6 ml 11.47 mmol) were dissolved in 20 mL of chloroform. 
Thionyl chloride (1 ml, 13.76 mmol) was added drop wise under a dinitrogen atmosphere 
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maintaining the temperature between 5 and 10 °C. After the addition was complete, the mixture 
was heated under reflux for 3 h at the end of which a brown solution was obtained. The mixture 
was cooled to room temperature, then a solution of amino pyridine (1.08 g, 11.47 mmol), 
triethylamine (1.6 ml, 11.47 mmol), and acetonitrile (20 mL) was added in situ and stirred at 
room temperature overnight. The organic layer was washed with water, and the solvent was 
removed. Column chromatography gave a white powder as the product. Yield 41%, mp 138−140 
°C (lit. 136−138 °C).10 1H NMR (δH, 400 MHz, MeOD): 8.748 (s, 2H), 8.363 (s, 1H), 8.245 (d, J 
= 8.2 Hz, 1H), 7.902−7.801 (m, 3H), 7.208−7.153 (m, 1H). 
 2.2.2 IR spectroscopy screening of co-crystals 
The ligands 3N and 4N were initially combined with even and odd-chain diacids to 
prepare co-crystal formation using solvent-drop assisted grinding. 3N/4N and the co-formers 
were combined in a 1:1 stoichiometry in a motor and pestle. A drop of methanol was added and 
the mixture was ground for 30 seconds. The resulting product was screened using IR 
spectroscopy to confirm co-crystal formation via two broad O-H···N stretches in the 1800-2500 
cm
-1 
region and also a significant shift in the acid C=O stretch. All samples that showed a 
positive hit for co-crystal formation were then subjected to slow evaporation experiments to 
grow single crystals suitable for X-ray diffraction analysis.   
 2.2.3 Synthesis of co-crystals using slow evaporation  
 2.2.3.1 (N-(3-pyridin-2yl)nicotinamide) malonic acid (1:1), 3N-MA 
A solution of 3N (10 mg, 0.05 mmol) in 2 mL of ethyl acetate was mixed with malonic 
acid (5.23 mg, 0.05 mmol) in 2 mL of ethyl acetate and warmed. Transparent rod-like crystals 
were obtained within few weeks. Mp 125−127 °C. 
 2.2.3.2 (N-(3-pyridin-2yl)nicotinamide) glutaric acid (1:1), 3N-GA 
A solution of 3N (10 mg, 0.05 mmol) in 2 mL of ethyl acetate was mixed with glutaric 
acid (6.6 mg, 0.05 mmol) in 2 mL of isopropanol and warmed. Transparent rod-like crystals 
were obtained within 40 days. Mp 94-97 °C. 
 2.2.3.3 (N-(3-pyridin-2yl)nicotinamide) pimelic acid (1:1), 3N-PA 
22 
 
A solution of 3N (10 mg, 0.05 mmol) in 2 mL of ethyl acetate was mixed with pimelic 
acid (8.0 mg, 0.05 mmol) in 2 mL of ethyl acetate and warmed. Transparent rod-like crystals 
were obtained. Mp 119−120 °C. 
 2.2.3.4 (N-(3-pyridin-2yl)nicotinamide) azelaic acid (1:1), 3N-AzA 
A solution of 3N (10 mg, 0.05 mmol) in 2 mL of ethyl acetate was mixed with azelaic 
acid (9.41 mg, 0.05 mmol) in 2 mL of ethyl acetate and warmed. Needle-like crystals were 
formed. Mp 90−93 °C. 
 2.2.3.5 (N-(3-pyridin-2yl)nicotinamide) succinic acid (1:1), 3N-SA 
A solution of 3N (10 mg, 0.05 mmol) in 2 mL of ethyl acetate was mixed with succinic 
acid (5.9 mg, 0.05 mmol) in 2 mL of ethyl acetate and warmed. Transparent needle-shaped 
crystals were obtained. Mp 145−147 °C. 
 2.2.3.6 (N-(3-pyridin-2yl)nicotinamide) adipic acid (1:1), 3N-AA 
A solution of 3N (10 mg, 0.05 mmol) in 2 mL of ethyl acetate was mixed with adipic acid 
(7.31 mg, 0.05 mmol) in 2 mL of ethyl acetate and warmed. Transparent block-shaped crystals 
were formed. Mp 140−142 °C. 
 2.2.3.7 (N-(3-pyridin-2yl)nicotinamide) sebacic acid (1:1), 3N-SeA 
A solution of 3N (10 mg, 0.05 mmol) in 2 mL of ethyl acetate was mixed with sebacic 
acid (10.11 mg, 0.05 mmol) in 2 mL of ethyl acetate and warmed. Needle-shaped crystals were 
formed in four weeks. Mp 104−106 °C. 
 2.2.3.8 (N-(4-pyridin-2yl)isonicotinamide) glutaric acid (1:1), 4N-GA 
A solution of 4N (10 mg, 0.05 mmol) in 2 mL of ethyl acetate was mixed with glutaric 
acid (6.6 mg, 0.05 mmol) in 2 mL of ethyl acetate and warmed. Transparent rod-like crystals 
were obtained within 20 days. Mp 127−129 °C. 
 2.2.3.9 (N-(4-pyridin-2yl)isonicotinamide) pimelic acid (1:1), 4N-PA 
A solution of 4N (10 mg, 0.05 mmol) in 2 mL of ethyl acetate was mixed with pimelic 
acid (8.0 mg, 0.05 mmol) in 2 mL of ethyl acetate and warmed. Transparent needle-like crystals 
were obtained in one month. Mp 123−125 °C. 
23 
 
 2.2.3.10 (N-(4-pyridin-2yl)isonicotinamide) azelaic acid (1:1), 4N-AzA 
A solution of 4N (10mg, 0.05mmol) in 2 ml of ethyl acetate was mixed with azelaic acid 
(9.41mg, 0.05 mmol) in 2 ml ethyl acetate and warmed. Transparent needle-like crystals were 
formed after 45 days. Mp 92-95 
o
C. 
 2.2.3.11 (N-(4-pyridin-2yl)isonicotinamide) succinic acid (1:1), 4N-SA 
A solution of 4N (10mg, 0.05mmol) in 2 ml of ethyl acetate was mixed with succinic acid 
(5.9mg, 0.05mmol) in 2 ml ethyl acetate and warmed. Transparent needles were obtained in 2 
months. Mp 122-125 
o
C. 
 2.2.3.12 (N-(4-pyridin-2yl)isonicotinamide) adipic acid (1:1), 4N-AA 
A solution of 4N (10mg, 0.05mmol) in 2 ml of ethyl acetate was mixed with adipic acid 
(7.31mg, 0.05mmol) in 2 ml ethyl acetate and warmed. Transparent block-shaped crystals were 
formed in three weeks. Mp 142-145 
o
C. 
 2.2.3.13 (N-(4-pyridin-2yl)isonicotinamide) suberic acid (1:1), 4N-SuA 
A solution of 4N (10mg, 0.05mmol) in 2 ml of ethyl acetate was mixed with suberic acid 
(8.71mg, 0.05mmol) in 2 ml ethyl acetate and warmed. Transparent rod-shaped crystals were 
obtained within a few weeks. Mp 133-135 
o
C. 
 2.2.3.14 (N-(4-pyridin-2yl)isonicotinamide) sebacic acid (1:1), 4N-SeA 
A solution of 4N (10mg, 0.05mmol) in 2 ml of ethyl acetate was mixed with sebacic acid 
(10.11mg, 0.05mmol) in 2 ml ethyl acetate and warmed. Transparent rod-like crystals were 
formed within a month. Mp 104-107 
o
C. 
 2.3 Results 
With the diacids, seven crystal structures were obtained out of eight co-crystallization 
experiments for 3N and 4N, respectively. Although IR spectroscopy confirmed a co-crystal for 
3N-SuA and 4N-MA combination during the solvent assisted grinding method, single crystals 
suitable for X-ray diffraction analysis could not be grown for 3N-SuA and 4N-MA. Table 2.1 
lists the IR stretches for O-H···N hydrogen bonds and the C=O stretch in the acid and 
corresponding co-crystal. Detailed hydrogen bond geometries for 3N and 4N co-crystals with the 
diacids are listed in Table 2.2 and 2.3, respectively. 
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Table 2.1 Summary of IR spectroscopy data for 3N and 4N co-crystals 
Compound O-H···N stretches 
(cm
-1
) 
C=O stretch (cm
-1
) 
(acid) 
C=O stretch (cm
-1
) 
(co-crystal) 
3N-MA 2439; 1871 1693 1701 
3N-GA 2450; 1850 1682 1680 
3N-PA 2487; 1877 1683 1686 
3N-AzA 2495; 1887 1682 1684 
3N-SA 2406; 1887 1686 1679 
3N-AA 2430; 1895 1683 1695 
3N-SeA 2509; 1886 1682 1683 
4N-GA 2492; 1862 1682 1687 
4N-PA 2357; 1883 1683 1687 
4N-AzA 2488; 1875 1682 1683 
4N-SA 2481; 1890 1686 1685 
4N-AA 2492; 1862 1683 1687 
4N-SuA 2471; 1907 1684 1683 
4N-SeA 2483; 1877 1682 1684 
 
Table 2.2 Hydrogen bond geometries in 3N co-crystals
a 
Structure D-H...A D-H/A H...A/A D...A/A D-H-N/o 
3N-MA N17 H17 O32   0.921(16) 2.225(16) 3.1144(13) 162.1(13) 
 O31 H31 N21   0.969(16) 1.647(16) 2.5945(13) 164.8(14) 
 O33 H33 N11_#1   0.971(17) 1.666(17) 2.6344(13) 174.9(15) 
3N-GA O31 H31 N11 0.958(16) 1.703(17) 2.6573(12) 173.6(15) 
 N17 H17 O36_#1 0.860(14) 2.005(14) 2.8599(11) 172.6(13) 
 O35 H35 N21_#2 0.940(17) 1.772(17) 2.7045(11) 171.0(14) 
3N-PA N17_1 H17_1 O32_1   0.90(2) 2.08(2) 2.975(2) 172.3(19) 
 N17_2 H17_2 O32_2   0.89(2) 2.06(2) 2.943(2) 172(2) 
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 O31_1 H31_1 N21_1   1.04(2) 1.63(2) 2.6672(19) 172.5(19) 
 O31_2 H31_2 N21_2   0.88(2) 1.78(2) 2.6611(19) 176(2) 
 O37_1 H37_1 N11_2   0.91(2) 1.77(2) 2.672(2) 172.1(19) 
 O37_2H37_2 N11_1_#1   1.01(2) 1.64(2) 2.647(2) 172.7(18) 
3N-AzA O31 H31 N11 1.00(2) 1.71(2) 2.7055(17) 171.3(18) 
 N17 H17 O40_#1   0.906(19) 2.074(19) 2.9785(17) 176.7(16) 
 O39 H39 N21_#2   0.95(2) 1.71(2 2.6491(17) 169.6(19 
3N-SA O31 H31 N11 0.96(2) 1.70(2) 2.6581(19) 172(2) 
 N17 H17 O35_#1   0.85(2) 2.12(2) 2.9674(19) 170(2) 
 O34 H34 N21_#1   0.90(2) 1.79(2) 2.6702(18) 169(2) 
3N-AA O31 H31 N11   0.909(17) 1.780(17) 2.6832(12) 172.0(14) 
 N17 H17 O36_#1   0.924(14) 2.009(14) 2.9271(11) 172.2(12) 
 O37 H37 N21_#1 0.970(17) 1.721(17) 2.6785(11) 168.6(14) 
3N-SeA O31 H31 N11   0.898(18) 1.795(18) 2.6898(14) 174.4(16) 
 O41 H41 N21_#1  0.89(2) 1.79(2) 2.6579(14) 166.3(18) 
 N17 H17 O42_#1  0.88 2.05 2.9131(13) 168.0 
 
a
Symmetry codes: 3N−MA: #1 x,1 − y,−0.5 + z. 3N-GA: #1 x, -y+1/2, z+1/2. #2 x, -y+1/2, z-1/2. 3N−PA: #1 −2 + 
x, 1 + y, 1 + z. 3N−AzA: #1 −0.5 −x, 0.5 + y, 0.5 − z. #2 −0.5 − x, −0.5 + y, 0.5 − z. 3N−SA: #1 −x, 1 − y, 1 − z. 
3N−AA: #1 −x, 1 − y, −z. 3N−SeA: #1 2 − x, 1 − y, 1 − z. 
 
Table 2.3 Hydrogen bond geometries in 4N co-crystals
b 
Structure D-H...A D-H/A H...A/A D...A/A D-H-N/o 
4N-GA O31 H31 N11   0.962(17)  1.712(17)  2.6713(11)  174.6(14) 
 N17 H17 O36_#1 0.855(14) 2.164(14) 3.0103(11) 170.7(13)   
 O35 H35 N21_#1   0.898(15) 1.786(15) 2.6570(11) 162.9(15) 
4N-PA N17 H17 O32 0.90(3) 2.08(3) 2.970(3) 173(2) 
 O31 H31 N21 0.95(3) 1.74(3) 2.679(3) 169(3) 
 O37 H37 N11   1.10(3) 1.57(3) 2.665(3) 172(2) 
4N-AzA O31 H31 N21   0.942(15) 1.738(15) 2.6756(11) 173.6(13) 
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 N17 H17 O32   0.862(14) 2.063(14) 2.9200(12) 172.7(12) 
 O39 H39 N11_#1   0.957(15) 1.785(15) 2.7413(12) 176.3(13) 
4N-SA N17_1 H17_1 O52_1 0.89(2) 2.12(2) 3.005(2) 174(2) 
 N17_2 H17_2 O52_2   0.92(2) 2.13(2) 3.050(2) 174.8(19) 
 N17_3 H17_3 O52_3   0.91(2) 2.09(2) 3.001(2) 176.5(18) 
 O51_1 H51_1 N21_1 0.97(2) 1.70(2) 2.661(2) 170(2) 
 O51_2 H51_2 N21_2     0.96(2) 1.75(2) 2.691(2 165(2) 
 O51_3 H51_3 N21_3   1.00(2) 1.69(2) 2.681(2) 170(2) 
 O54_1 H54_1 N41_1   0.98(2) 1.72(2) 2.685(2) 171(2) 
 O54_2 H54_2 N41_2 0.97(2) 1.74(2) 2.679(2) 162.4(19) 
 O54_3 H54_3 N41_3 0.94(2) 1.79(2) 2.702(2) 165(2) 
 O61_1 H61_1 N11_1   0.96(2) 1.72(2) 2.667(2) 173(2) 
 O61_2 H61_2 N11_2   0.93(2) 1.75(2) 2.668(2) 170(2) 
 O61_3 H61_3 N11_3   0.97(2) 1.72(2) 2.683(2) 173(2) 
 O64_1 H64_1 N31_1_#1   0.90(2) 1.80(3) 2.688(2) 168(2) 
 O64_2 H64_2 N31_2_#1   0.93(2) 1.74(2) 2.670(2) 175(2) 
 O64_3 H64_3 N31_3 _#1  0.94(3) 1.72(3) 2.659(2) 170(2) 
4N-AA N17 H17 O42   0.856(18) 2.058(18) 2.9131(14) 177.4(17) 
 O31 H31 N11   0.98(2) 1.73(3) 2.6945(15) 169(2) 
 O41 H41 N21   0.94(2) 1.74(2) 2.6772(14) 172.3(19) 
4N-SuA O31 H31 N11   1.03(2) 1.69(2) 2.7133(15) 179.3(18) 
 N17 H17 O39_#1   0.850(16) 2.077(16) 2.9228(13) 173.6(14) 
 O38 H38 N21_#2 1.120(17) 1.541(17) 2.6583(13) 175.3(14) 
4N-SeA O31 H31 N11   0.999(15) 1.674(15) 2.6693(12) 174.2(13) 
 N17 H17 O41_#1   0.855(14) 2.002(14) 2.8556(12) 176.2(13) 
 O40 H40 N21_#2   1.013(15) 1.626(15) 2.6327(12) 172.0(13) 
 
b
Symmetry codes: 4N−GA: #1 1 − x,−y, 1 − z. 4N−PA: #1 2.5 − x, −0.5 + y, 1.5 − z. 4N−AzA: #1 −1 − x, −y, 1 − z. 
4N−SA: #1 −1 + x, −1 + y, z. 4N−SuA: #1 0.5 − x, −0.5 + y, 1.5 − z. #2 0.5 − x, 0.5 + y, 1.5 − z. 4N−SeA: #1 0.5 − 
x, 0.5 + y, 1.5 − z. #2 0.5 − x, −0.5 + y, 1.5 − z. 
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 2.3.1 Structural description of co-crystals 
 2.3.1.1 Crystal structure of 3N:MA 
A co-crystal is formed between 3N and malonic acid via two different primary hydrogen 
bonds; O-H···N(py), 2.594(13) Å and O-H···N(aminopy), 2.634(13)  Å on either side of the 
diacid. The resulting structure is a 1-D infinite chain-like architecture (Fig 2.6).  
 
              Figure 2.6 1-D chain formed in the co-crystal of 3N:MA 
 2.3.1.2 Crystal structure of 3N:GA 
The crystal structure of 3N:GA shows a co-crystal formed between 3N and GA via two 
unique hydrogen bonds, O-H···N(py) and O-H···N(aminopy) with bond distances of 2.657(12)  
and 2.704(11) Å, respectively. The resulting architecture is an infinite 1-D zig-zag chain (Fig 
2.7).  
 
            Figure 2.7 1-D zig-zag chain in the 3N:GA co-crystal 
 2.3.1.3 Crystal structure of 3N:PA 
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In the 3N:PA co-crystal, primary synthons formed are the O-H···N(py) and O-
H···N(aminopy) hydrogen bond with bond distances of 2.647(2) Å and 2.661(19) Å, 
respectively, resulting in a 1-D planar chain-like structure (Fig 2.8). 
 
           Figure 2.8 1-D infinite chains formed in the 3N:PA co-crystal 
 2.3.1.4 Crystal structure of 3N:AzA 
In 3N:AzA, azelaic acid interacts on both sides with 3N via COOH-N(py), 2.705(17)  Å 
and COOH-N(aminopy), 2.649(17) Å hydrogen bonds. It is interesting to note that unlike in 
3N:MA, 3N:GA and 3N:PA, in 3N:AzA, the O-H···N bond distance for acid-pyridine 
interaction is shorter than the acid-aminoyridine interaction. The resulting architecture resembles 
infinite corrugated chains (Fig 2.9).  
 
            Figure 2.9 1-D corrugated chains in the 3N:AzA co-crystal 
 2.3.1.5 Crystal structure of 3N: SA 
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In 3N:SA co-crystal the primary synthons are the robust O-H···N(py), 2.658(19) Å and 
O-H···N(aminopy), 2.670(18)  Å hydrogen bonds that result in the formation of tetrameric rings 
(Fig 2.10).  
 
                                                Figure 2.10 0-D ring in the 3N:SA co-crystal 
 2.3.1.6 Crystal structure of 3N:AA 
The crystal structure of 3N:AA shows a 1:1 co-crystal between 3N and adipic acid. O-
H···N(py), 2.683(12) Å and O-H···N(aminopy), 2.678(11) Å are the primary interactions that 
direct the assembly of tetrameric 0-D ring (Fig 2.11).  
 
          Figure 2.11 0-D ring architecture in the 3N:AA co-crystal 
 2.3.1.7 Crystal structure of 3N:SeA 
The crystal structure of 3N:SeA consist of a 1:1 co-crystal between 3N and sebacic acid. 
The acid binds to 3N on either sides via short O-H···N(py), 2.689(14) Å and O-H···N(aminopy), 
2.657(14)  Å hydrogen bonds. The resulting assembly is a tetrameric ring (Fig 2.12). 
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             Figure 2.12 0-D ring architecture in the co-crystal of 3N:SeA 
 2.3.1.8 Crystal structure of 4N:GA 
The crystal structure of 4N:GA shows a 1:1 co-crystal formed using both O-H···N(py), 
2.671(11) Å and O-H···N(aminopy), 2.657(11) Å hydrogen bonds. The interactions result in  0-
D rings (Fig 2.13). 
 
             Figure 2.13 0-D tetrameric ring in the 4N:GA crystal structure 
 2.3.1.9 Crystal structure of 4N:PA 
The crystal structure of 4N:PA displays an infinite 1-D zig-zag chain formed via O-
H···N(py), 2.665(3) Å and O-H···N(aminopy), 2.679(3) Å hydrogen bonds (Fig 2.14). 
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        Figure 2.14 1-D zig-zag chains formed in the 4N:PA co-crystal 
 2.3.1.10 Crystal structure of 4N:AzA 
The crystal structure of 4N:AzA is a 1:1 co-crystal formed between 4N and azelaic acid 
via O-H···N(py), 2.741(12) Å and O-H···N(aminopy), 2.676(11) Å hydrogen bonds (Fig 2.15). 
The acid-pyridine bond distance is comparatively longer than the acid-aminopyridine bond 
distance. The resulting assembly is a tetrameric ring. 
 
Figure 2.15 0-D tetrameric ring in the 4N:AzA co-crystal 
 2.3.1.11 Crystal structure of 4N:SA 
The crystal structure of 4N:SA displays infinite 1-D zig-zag planar chains formed using 
strong hydrogen bond interactions, i.e. O-H···N(py), 2.688(2) Å and O-H···N(aminopy), 
2.660(2) Å (Fig 2.16).  
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             Figure 2.16 Infiite 1-D zig-zag chains formed in 4N:SA co-crystal 
 2.3.1.12 Crystal structure of 4N:AA 
The crystal structure of 4N:AA displays infinite 1-D  corrugated chains formed via  
intermolecular O-H···N(py), 2.695(15) Å and O-H···N(aminopy), 2.677(14) Å hydrogen bonds 
(Fig 2.17). 
 
 
        Figure 2.17 1-D infinite corrugated chains in 4N:AA co-crystal structure 
 2.3.1.13 Crystal structure of 4N:SuA 
The crystal structure of 4N:SuA displays 1-D corrugated chain formed via strong 
intermolecular hydrogen bond interactions on either sides of suberic acid, i.e. O-H···N(py), 
2.713(15) Å and O-H···N(aminopy), 2.658(13) Å (Fig 2.18).  
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Figure 2.18 1-D corrugated chain-like assembly in 4N:SuA co-crystal 
 2.3.1.14 Crystal structure of 4N:SeA 
In 4N:SeA co-crystal, the primary synthons O-H···N(py), 2.669(12) Å and O-
H···N(aminopy), 2.633(12) Å hydrogen bonds drive the assembly into an infinite 1-D corrugated 
chain-like architecture (Fig 2.19). 
 
           Figure 2.19 1-D corrugated chains in 4N:SeA crystal structure 
 2.3.2  Isostructural co-crystals 
Isostructural crystals have the same space group and similar cell dimensions. A summary 
of the unit cell parameters for the crystal structures of 3N and 4N co-crystals are given in Table 
2.4 and 2.5, respectively.  
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Table 2.4 Unit cell parameters of 3N co-crystals 
Co-crystal 3N:MA 3N:GA 3N:PA 3N:AzA 3N:SA 3N:AA 3N:SeA 
Crystal 
system 
Monoclinic Monoclinic Triclinic Monoclinic Triclinic Triclinic Triclinic 
Space 
group,  Z 
C2/c, 8 P 2(1)/c, 4 P-1, 4 P2(1)/n, 4 P-1, 2 P-1, 2 P-1, 2 
a, Å 31.2168(18) 7.2374(6) 7.5711(5) 13.5588(13) 4.8289(5) 8.9361(8) 7.5703(8) 
b, Å 4.7940(3) 11.1991(10) 11.9820(8) 9.4660(10) 11.1223(11) 9.8031(9) 9.6882(10) 
c, Å 22.7743(13) 19.5063(17) 20.1758(13) 15.8384(15) 14.3787(14) 9.8270(9) 13.9977(14) 
, ° 90.00 90.00 82.560(4) 90.00 67.856(4) 83.130(2) 85.455(4) 
, ° 128.375(2) 90.267(3) 80.081(4) 105.946(4) 89.550(4) 74.507(3) 81.210(4) 
, ° 90.00 90.00 85.195(4) 90.00 87.878(4) 79.462(2) 79.358(4) 
Volume, 
Å
3
 
2671.9(3) 1581.01 1784.2(2) 1954.6(3) 714.79(12) 813.31(13) 995.74(18) 
 
Table 2.5 Unit cell parameters of 4N co-crystals 
Co-
crystal 
4N:GA 4N:PA 4N:AzA 4N:SA 4N:AA 4N:SuA 4N:SeA 
Crystal 
system 
Triclinic Monoclinic Triclinic Triclinic Monoclinic Monoclinic Monoclinic 
Space 
group,  Z 
P-1, 2 P2(1)/n, 4 P-1, 2 P-1, 12 P2(1)/c, 4 P2(1)/n, 4 P2(1)/n, 4 
a, Å 5.1663(6) 7.5855(12) 5.6707(3) 11.2578(7) 11.9508(11) 11.4438(7) 11.0319(11) 
b, Å 9.9211(10) 21.675(3) 10.8221(6) 19.6623(11) 19.8752(19) 10.1874(5) 9.9500(9) 
c, Å 15.8829(17) 11.1031(16) 17.0848(10) 19.8130(12) 7.3996(8) 16.5671(9) 18.7354(18) 
, ° 75.339(3) 90.00 104.161(2) 93.236(3) 90.00 90.00 90.00 
, ° 82.551(3) 96.050(9) 94.599(2) 91.236(3) 105.384(4) 95.023(3) 90.323(4) 
, ° 78.820(3) 90.00 104.840(2) 90.298(3) 90.00 90.00 90.00 
Volume, 
Å
3
 
769.84(14) 1815.4(5) 971.22(9) 4377.6(5) 1694.6(3) 1924.02(18) 2056.5(3) 
 
The following co-crystals are isostructural and their volume increases in proportion to the 
increase in number of carbon atoms in the acid chain; 
 3N:GA and 3N:AzA 
 4N:GA and 4N:AzA 
 4N:AA, 4N:SuA and 4N:SeA 
The melting points of isostructural co-crystals within the same series show a decreasing trend 
with an increase in the number of carbon atoms in the corresponding diacids (Section 2.2.3).  
 2.4 Discussion 
 2.4.1 Co-crystals vs salts 
All co-crystals were constructed using hydrogen bonds between an acid and a pyridine 
acceptor. This reaction however, could have also resulted in the formation of salts, wherein a 
35 
 
proton gets transferred from the acid to the pyridine nitrogen. This would result in an O
-
···H-N
+
 
charge assisted interaction instead of a neutral O-H···N hydrogen bond. IR spectroscopy and 
single crystal structural data were used to interpret our results and confirm the formation of co-
crystals.  
 2.4.1.1 Characterization using IR spectroscopy 
In our set of experiments we have obtained 14/14 co-crystals, i.e. 100% supramolecular 
yield. All fourteen co-crystallization experiments were first screened using IR spectroscopy. Co-
crystal formation was confirmed by two broad stretches in the 1800-2500 cm
-1
 region, 
representing the intermolecular O-H···N hydrogen bond (Fig 2.20). In addition, the C=O stretch 
in all cases was above 1670 cm
-1
 (Table 2.1) which further confirms co-crystal formation and not 
salts, since in salts the C-O stretch which is now a part of the COO- anion shows up lower than 
1670 cm
-1 
. 
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            Figure 2.20 IR spectra of 4N (top) and 4N:AA (bottom) indicating the two broad O-
H...N stretches 
 2.4.1.2 Characterization using structural data analysis 
Apart from the IR spectroscopy data, a closer look at the two C-O bond lengths of the 
acid moiety as well as the endocyclic C-N-C bond angle confirm co-crystal formation in all 
cases.
11
 In order to compare the C-O bond distances in neutral acid and a salt a CSD search was 
performed on carboxylic acids (7807 hits) and ionic carboxylates (98 hits). In neutral acid moiety 
the average C=O bond distance is 1.21(6) Å and the average C-O bond distance is 1.31(2) Å. 
While in ionic species, the two C-O stretches in the carboxylate anion (COO
-
) get a double bond 
character due to electron pair delocalization and hence have the same bond distance, i.e.1.24 (13) 
Å, Fig 2.21. An analysis of our crystal structures indicate that the C=O bond distance fall in the 
range of 1.205-1.213Å while the C-O bond distance falls in the range of 1.301-1.328Å, which is 
indicative of a neutral carbonyl group and thus a co-crystal formation, Tables 2.2 and 2.3. CSD 
search was also performed on neutral (17668 hits) and ionic (2443 hits) C-N-C bond angle in 
pyridine type compounds. The C-N-C bond angle for the protonated form was above 120°, 
i.e.122.5°(sd=1.5), while the non-protonated C-N-C bond angle is below 120°, i.e.118.1° 
(sd=2.3), Fig 2.21. In our crystal structures, the C-N-C bond angle values fall in the range of 
116.21-118.78° which represents the non-protonated form of pyridine moiety.  
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Figure 2.21 Comparing C-O and C=O bond distances and C-N-C bond angles in neutral 
(left) vs ionic moities (right) 
 2.4.2 Hetero- synthons directing the co-crystal assembly  
All fourteen co-crystals were constructed using the robust O-H···N(py) (acid-pyridine) and 
O-H···N(ampy) (acid-aminopyridine) hydrogen bonds to form either 0-D rings or 1-D chains. A 
CSD search of the acid-pyridine heterosynthon gave a total of 1125 hits with the O-N bond 
distance (in O-H···N(py)) in the range of 2.5-3.50 Å (Fig 2.22) and average value of 2.73(9) Å. In 
our data set, the O-N bond distances in O-H···N(py) hydrogen bond interactions fall in the range 
of 2.59-2.74 Å, with an average value of 2.63 Å. A CSD search on the acid-aminopyridine 
heterosynthon gave a total of 87 hits with O-N distances in the range of 2.538-3.452 Å (Fig 2.23) 
and an average of 2.797(63) Å. In our data set, the O-N bond distances in O-H···N(aminopy) 
hydrogen bond interactions fall in the range of 2.632-2.704 Å, with an average value of 2.618 Å.  
The values of O···N bond distances in our set of co-crystals fall well within the range of 
literature values and are very comparable. The number of hits in the database coupled with our 
consistent results signify the robustness and reliability of the acid-pyridine and acid-
aminopyridine heterosynthons in constructing supramolecular architectures. 
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Figure 2.22 Histogram showing O-N(py) bond distance in acid-pyridine heterosynthon  
                                     
Figure 2.23 Histogram showing O-N(ampy) bond distance  in acid-aminopyridine 
heterosynthon 
 2.4.3 Assessing the co-crystal assemblies  
In order to examine the role of binding site complementarity in directing the 
supramolecular solid-state structure, two isomeric pyridine based acceptors 3N and 4N were 
combined with four even and four odd-chain diacids, respectively. Out of the sixteen 
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combinations, we successfully obtained crystal structures for fourteen co-crystals. Two distinctly 
different types of supramolecular assemblies were formed depending upon the choice of the 
interacting pairs. The primary driving force in all crystal structures was the acid-pyridine and 
acid-aminopyridine heterosynthons. However, the final structural outcome was an infinite 1-D 
chain in 3N:odd (Fig 2.24) and 4N:even (Fig 2.25) diacid pairs, and a 0-D cyclic assembly in 
3N:even (Fig 2.26)  and 4N:odd (Fig 2.27) diacid pairs (4N:PA, Figure 2.27 was the only outlier 
that formed chains instead of the expected ring in 4N:odd series). As we are dealing with 
relatively weak and reversible forces, the preferential construction of 1-D or 0-D assembly 
within selected pairs is clearly indicative of the geometric complementarity that exists between 
the given acid-base pairs. Thus, the observed outlier may be a polymorph as we do not see any 
reason why 4N and pimelic acid combination should behave differently from the others in the 
same series.  
 
Figure 2.24 1-D chains in 3N:odd co-crystals a) 3N:MA b) 3N:GA c) 3N:PA and d) 3N:AzA 
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Figure 2.25 1-D chains in 4N:even co-crystals a) 4N:SA b) 4N:AA c) 4N:SuA and d) 4N:SeA 
 
 
Figure 2.26 0-D rings in 3N:even co-crystals a) 3N:SA b) 3N:AA and c) 3N:SeA 
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Figure 2.27 0-D rings in co-crystals of a) 4N:GA b) 1-D chain in 4N:PA  and c) 4N:AzA,  
 
Another interesting observation to note is the orientation of the carbonyl group and 
pyridine nitrogen in 3N:odd diacid series where they are „syn‟ with respect to each other in 
3N:MA, 3N:GA and 3N:PA co-crystals but „anti‟ in the 3N:AzA co-crystal. This discrepancy 
however does not seem to have any effect on the resulting assembly, i.e. all four co-crystals in 
the series give 1-D chains.
12
 
We can conclude that although the primary recognition between the acid and pyridyl 
moiety occurs through the formation of O-H···N hydrogen bond, the assembly process is 
governed by the number of carbon atoms in the diacid chain and the precise orientation of 
binding sites in the co-crystallizing agents. Along similar lines, Pedireddi et.al,
13
 designed an 
experiment to check the dependence of the resulting crystal structure on the number of carbon 
atoms in the diacid chains, Using 4,4‟-bipyridine as the acceptor and odd-even chain di-
carboxylic acids (malonic, glutaric and adipic acid) as the donor, they had postulated two distinct 
types of architectures; chains with even diacid and rings with odd diacid. However, contrary to 
their expectations 4,4‟-bipyridine formed chains with malonic, glutaric and adipic acid, 
irrespective of the number of carbon atoms in the diacid backbone. The difference between their 
acceptor system and ours is the orientation of the binding sites. In 4,4‟-bipyridine, the binding 
sites are co-linear whereas in our system they are parallel (3N) and at an angle of 60° (4N) (Fig 
2.28). 
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Figure 2.28 Arrows indicating the orientation of binding sites in a) 3N b) 4N c) 4,4’-
bipyridine 
 2.5 Conclusion 
In conclusion, we have synthesized two acceptors 3N and 4N using slightly modified 
literature procedures and performed co-crystallization experiments to examine the potential of 
the ligands for forming co-crystals with a series of diacids. A remarkable degree of structural 
consistency is observed within the given groups of interacting species. We postulated two 
different types of architectures, chains and rings for the combination of 3N/4N with odd/even 
dicarboxylic acid. Based on our structural analysis of fourteen co-crystals, rings were formed 
when 3N was combined with even diacids and when 4N was combined with odd diacids. On the 
other hand, chains were formed with 3N:odd diacids and 4N:even diacids pairs. A correlation is 
observed between the molecular geometries of interacting species and the resulting assembly 
(Fig 2.29).  
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Figure 2.29 Results of the postulated structural outcome 
 
We have thus identified a reliable supramolecular method for constructing solid-state 
architectures with a high degree of structural control and reproducibility using a simple mix and 
match strategy.
12
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Chapter-3 Correlating molecular properties with physical 
properties of bulk solids 
 3.1 Introduction 
The discovery and formulation of a new drug is an extremely expensive and time 
consuming process (Fig 3.1).
1
 Poor oral bioavailability still remains one of the main reasons for 
why less than 1% of active compounds make it to the market.
2
 Oral bioavailability is the fraction 
of an orally administered drug that reaches systemic circulation. A higher bioavailability means 
lower administered drug dosage is needed and this reduces the risk of side effects and toxicity. 
On the other hand, low bioavailability demands increased dosage of the drug and thus poor 
efficacy. Aqueous solubility and membrane permeability of the drug are the two important 
determinants of the overall oral bioavailability. Solubility is a key physicochemical parameter 
that needs to be addressed in the initial stages of the drug development process.
3
 Table 3.1 
briefly summarizes the definition of solubility according to United States Pharmacopeia (USP).
4
   
 
Figure 3.1 Drug development time line
1 
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Table 3.1Solubility definition according to USP
4
 
 Solubility range 
(mg/ml) 
Very soluble (VS) >1,000 
Soluble(S) 33–100 
Sparingly soluble (SPS) 10–33 
Slightly soluble (SS) 1-10 
Very slightly soluble (VSS) 0.1–1 
Practically insoluble (PI) <0.1 
 
According to the Biopharmaceutical Classification System
5
 (BCS), active pharmaceutical 
ingredient (API) can be divided into four classes: Class 1, drug candidates that have good 
solubility as well as good permeability; Class II, drugs that have good membrane permeability 
but poor solubility; Class III, drugs with poor permeability and higher solubility; Class IV, drugs 
that are poorly soluble as well as poorly permeable through the membrane. The problem of low 
solubility of API has been addressed in a number of ways such as micronization
6
, salt 
formation
7
, solubilization in co-solvents
8
 and use of micellar solutions
9
.  
 
Figure 3.2 BCS classification of API’s5 
Recent advances in crystal engineering combined with the knowledge of reliable and 
predictable supramolecular synthons have led to extensive research in the design of 
Class I 
High Solubility 
High permeability 
Class II 
Low Solubility 
High permeability 
Class III 
High Solubility 
Low permeability 
Class IV 
Low Solubility 
Low permeability 
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pharmaceutical co-crystals.
10
 Pharmaceutical co-crystals are molecular complexes containing 
therapeutic molecules, i.e. an active pharmaceutical ingredient (API) along with co-former. Co-
crystals are formed through non-covalent interactions (Fig 3.3), i.e. without making or breaking 
of covalent bonds, and hence this technique can be used to fine-tune physical properties of API 
via precise control over molecular assembly, without affecting the therapeutic activity.  
 
Figure 3.3 Schematic representation of a pharmaceutical co-crystal 
The physical properties of crystalline materials are largely governed by the arrangement 
of molecules in the solid state. Alterations to this arrangement can bring about changes in the 
physical properties. Solubility of a given solute is based on free energy of solubilization, which 
is a combination of two factors, i.e. crystal lattice interactions as well as solute-solvent 
interactions (solvation) given by the equation, 
ΔGsolution = ΔGlattice + ΔGsolvation   
where ΔGsolution represents the Gibbs free energy for the solubilization process, ΔGlattice and 
ΔGsolvation are the free energies of lattice contribution and solvation, respectively.
11
 Solubility can 
be altered by changes in the lattice energies and/or solvation energies. Co-crystals have the 
ability to alter both, and thus influence the associated lattice and solvation energy.  
There are many examples in the literature where co-crystallizations have improved the 
solubility of API‟s.12 One notable example is Itraconazole (BCS class II drug) co-crystals with 
1,4-dicarboxylic acids (fumaric, succinic, malic and tartaric acid), which showed a 4-20 fold 
increase in the solubility as compared to the crystalline form of the drug itself.
13
 Another 
example is the co-crystals of an anti-cancer drug (Fig 3.4a) with a series of even-chain 
dicarboxylic acids that shows an enhancement in solubility compared to the drug itself. The co-
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crystal solubility decreases systematically with an increase in the hydrophobicity of the 
corresponding diacids.
14
  
 
Figure 3.4 (a) Structure of the anti-cancer drug, (b) Aqueous solubility of the drug and its 
co-crystals with dicarboxylic acids 
14
 
In this study we attempt to use co-crystallization as a tool to systematically fine-tune the 
solubility of two pyridine based ligands, 3N and 4N. Both 3N and 4N are potential mimics of the 
API Imatinib, a BCS Class II drug. All three have common binding sites; the pyridine nitrogen 
atom and the amino-pyridine site (Fig 3.5). Based on our knowledge of supramolecular synthons, 
the co-formers of choice for 3N and 4N are the even (succinic, adipic, suberic and sebacic) and 
odd-chain (malonic, glutaric, pimelic and azelaic) dicarboxylic acids. In Chapter 2 we have 
demonstrated the potential of these ligands to form co-crystals with the diacids and have mapped 
out their structural landscape through single crystal analysis. Both the pyridine as well as amino-
pyridine nitrogen atoms form hydrogen bonds with the diacids resulting in either a 0-D or 1-D 
assembly. 
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Figure 3.5 4N, 3N and Imatinib displaying common functional groups  
 
In this study, we aim to map the solubility of 3N and 4N co-crystals and also understand 
any correlations that might exist between the solubility of a co-crystal and molecular property of 
individual component.   
Our study will therefore cover the following points; 
i) Effect of co-crystallization on the solubility behavior of the mimics. 
ii) Correlation between co-crystal solubility and co-crystal melting point. 
iii) Correlation between co-crystal solubility and co-former solubility. 
iv) Effect of binding event on the resulting co-crystal solubilities using Isothermal 
Titration Calorimetry 
 3.2 Experimental 
 3.2.1 Synthesis  
 3.2.1.1 Synthesis of 3N and 4N 
The syntheses of 3N and 4N are presented in Ch 2, Section 2.2.1. 
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 3.2.1.2 Preparation of co-crystals for solubility studies 
Co-crystals of 3N and 4N with the even chain diacids succinic C4, adipic C6, suberic C8 
and sebacic acid C10 as well as  odd-chain diacids malonic C3, glutaric C5, pimelic C7 and 
azelaic acid C9 were prepared via a solvothermal method.
15
 The ligand and the acid were 
combined in a 1:1 ratio and refluxed in 25ml of methanol. After 40 min of heating, the resulting 
solution was cooled to 5 °C. The precipitated solid was filtered, dried and analyzed using IR 
spectroscopy to confirm co-crystal formation. The IR spectra of the bulk co-crystal matched the 
IR spectra of single crystals that were submitted for X-ray analysis. The PXRD patterns of the 
bulk and single crystal were also compared to confirm structural homogenity (Fig 3.6). The 
melting points of the co-crystals were determined on a Fisher- Johns melting point apparatus and 
are listed in Table 3.2. 
 
Figure 3.6 a) PXRD of bulk 3N:SA co-crystal synthesized by solvothermal method and b) 
PXRD from single crystal of 3N:SA 
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Table 3.2 Melting points of 3N and 4N co-crystals in °C 
 3N 4N 
Malonic acid C3 126 143 
Glutaric acid C5 96 128 
Pimelic acid C7 119 130 
Azelaic acid C9 92 94 
Succinic acid C4 146 124 
Adipic acid C6 141 144 
Suberic acid C8 127 134 
Sebacic acid C10 105 106 
 
 3.2.2 Solubility measurements 
 3.2.2.1 Equilibrium solubility of 3N and 4N  
In order to determine the equilibrium solubility of 3N and 4N, a saturated solution of 3N 
was prepared by dissolving 0.125g of 3N in 10ml of distilled water in a vial. The vial was sealed 
and stirred in a water bath to maintain constant temperature. After stirring for 12hrs at room 
temperature, the remaining solid was filtered and dried.  The weight of the left over solid was 
recorded. The concentration of the filtrate was determined by the mass difference of 3N in 10ml 
of the solvent. The experiment was carried out at different time intervals like 24hrs, 48hrs and 
72hrs. Similar procedure was followed for 4N.  
The resulting concentrations were plotted against the corresponding time intervals and 
the equilibrium concentration and time was determined (Table 3.3, Figures 3.7 and 3.8). 
Table 3.3 Concentration of 3N and 4N at different time intervals 
Time (hrs) 3N  
Concentration (M) 
4N  
Concentration (M) 
12 0.0061 0.0251 
24 0.0065 0.0273 
48 0.0091 0.0294 
72 0.0087 0.0298 
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Figure 3.7 Concentration vs time in 3N 
              
Figure 3.8 Concentration vs time in 4N 
 3.2.2.2 Calibration curve 
To construct a calibration curve, the stock solution of ligand was subjected to serial 
dilutions and their corresponding absorbance was recorded (Fig 3.9 and 3.10). The equation of 
the line was used for determining the unknown concentration of the ligand during co-crystal 
solubility measurements. 
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Figure 3.9 Calibration curve of 3N at 72hrs 
 
Figure 3.10 Calibration curve of 4N at 72hrs 
 3.2.2.3 Aqueous solubility measurement of 3N and 4N co-crystals 
A suspension of the co-crystal (0.125g) was stirred in 10ml of distilled water in a sealed 
vial and placed in a water bath to maintain constant temperature. After stirring for 72hrs, the 
remaining solid was filtered off. A 0.2 ml aliquot of the filtrate was diluted to 10ml using 
distilled water (dilution factor = 50) and the absorbance of 3N/4N was measured using UV-Vis 
spectroscopy, Shimadzu UV-1650-PC. The absorbance (y) values were used to calculate the 
corresponding concentrations (x) from the equation of line (y=mx+c) of the calibration curves. 
The calculated concentration was then multiplied by the dilution factor to get the final 
concentration and thus the solubility of the co-crystal. 
y = 12620x - 0.0247 
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 3.2.3 Isothermal Titration Calorimetry (ITC) 
Isothermal titration calorimetry (ITC) is a thermodynamic technique used to study 
interactions between molecules in the solution phase. When two molecules interact, heat is either 
released or gained by the system to form an energy-minimum stable complex.  The amount of 
heat lost or gained is a measure of the strength of the interaction between the two species. This 
can be analyzed in terms of thermodynamic parameters like enthalpy change (ΔH), entropy 
change (ΔS), Gibbs free energy changes (ΔG) of the system. The binding constants (Ka) and 
binding stoichiometry (N) can also be calculated.
16
  
 2.2.3.1 Experimental details of ITC 
In this study, ITC measurements were carried out for 3N and 4N with succinic and 
sebacic acid respectively. The sample and reference cell was rinsed with distilled water. The 
reference cell was filled with water (blank) and sample cell was filled with an aqueous solution 
of the donor (acids). The aqueous solution of the acceptor (3N/4N) was filled in a syringe (Table 
3.4). After letting the system equilibrate for about 1hr, 8μl of the acceptor solution was injected 
into the sample cell at intervals of 400s between each injection. 30 such injections were made in 
total and the change in enthalpy was measured after each injection. The experiment was repeated 
twice. 
Table 3.4 Details of the ITC experiment 
 Mass (mg) Vol (ml) Conc (mM) 
3N 23.90 10 11.99 
4N 23.90 10 11.99 
Succinic acid 0.18 10 0.15 
Sebacic acid 0.31 10 0.15 
 
Data analysis and data fit procedures were performed using the software NanoAnalyze. The 
signals from the experiment are plotted in μcal/sec as a function of time, interpreting the power 
needed to maintain the reference and sample cell at the same temperature. The number of pulses 
corresponds to the heat released/absorbed with injection of the ligand. These can be integrated to 
obtain the total heat change per injection 
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 3.3 Results and discussion 
 3.3.1 Modulating the solubility of 3N and 4N 
Based on the experimental measurements, the aqueous solubility of 3N and 4N are 1.692 
mg/ml and 5.757 mg/ml respectively. 4N is approximately 3.5 times more soluble than 3N. 
These mimics can be considered to be slightly soluble compounds (Table 3.1). The solubility in 
mg/ml for 3N and 4N are listed in Table 3.5. 
Table 3.5 Aqueous solubility of 3N and 4N co-crystals 
 3N (mg/ml) 4N(mg/ml) 
Malonic acid C3 7.376(60) 7.693(34) 
Glutaric acid C5 3.376(227) 4.074(19) 
Pimelic acid C7 2.899(66) 0.890(4) 
Azelaic acid C9 1.857(117) 0.662(40) 
Succinic acid C4 2.877(39) 4.131(45) 
Adipic acid C6 0.661(19) 0.922(13) 
Suberic acid C8 0.460(45) 0.301(56) 
Sebacic acid C10 0.113(5) 0.211(4) 
 
The experimental results indicate that the solubility of 3N and 4N can be modulated 
systematically via co-crystallizations with diacids (Fig 3.11 and 3.12, Table 3.5). In the series of 
even-chain diacid co-crystals with 3N, the shortest diacid, i.e. C4, displays a solubility four times 
higher than that of 3N itself. The remaining three co-crystals have solubility lower than 3N. 
However, with 3N:odd-diacid co-crystals, we have achieved a higher (four-fold) or similar 
solubility for all co-crystals (Fig 3.11).  
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Figure 3.11 Aqueous solubility of 3N and 3N co-crystals with even chain diacids (a), and 
odd chain diacids (b). 
In co-crystals of 4N with even-chain diacids, the solubility is reduced systematically from 
C4 to C10 with increasing hydrophobicity of the diacid. However in co-crystals of 4N with odd-
chain diacids, C-3 shows higher solubility than that of 4N. The other compounds in the series 
show a systematic decrease in the solubility (Fig 3.12).  
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Figure 3.12 Aqueous solubility of 4N and 4N co-crystals with even chain diacids (a), and 
odd chain diacids (b). 
Our results demonstrate the potential of co-crystallization as a tool for modifying the 
solubility of an organic molecular solid, i.e. the solubility can either be lowered or improved 
depending on the choice of co-crystallizing agents. The solubility decreases with increasing 
hydrophobicity of the acid co-former. 
 3.3.2 Correlation between solubility and melting point of co-crystals 
The melting point is a very important physical property of crystalline materials. In 
pharmacy, the general solubility equation is widely used to estimate the aqueous solubility of 
solutes. This equation takes into account two factors, i.e. melting point and partition co-efficient 
of the solute.
17
 While these predictions can be made for single component systems, the literature 
remains sparse when making such correlations in multi-component systems like co-crystals. 
There are two contrasting views in terms of correlating solubility and melting point. While some 
propose that they are correlated, few others believe that they are independent of each other.
18,19
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Solubilizing a co-crystal involves two main processes, (i) breaking of the non-covalent 
interaction in a co-crystal to release the solute from the crystal lattice and (ii) solvation of the 
released solute molecule.  Both these factors contribute to the free energy of solvation.
20
 Hence, 
since solvation also plays a role in solubilizing molecules, accurate prediction of solubility based 
on thermal properties alone can prove inaccurate and unreliable. There are several examples in 
the literature that demonstrate how melting point of a co-crystal is not an accurate measure in 
predicting aqueous solubility.
19
 For instance, a recent study on co-crystals of AMG-517 with 
structurally diverse co-formers found no correlation between the melting points and log of 
solubility of the co-crystals.
21
 In another example, the experimental solubility values of 
Gabapentin-Lactam (GBPL) co-crystals were found to be different from the calculated ideal 
solubility values that was measured based on thermal properties of the co-crystal using the 
equation, 
          
   
      
(
    
   
),  
where        is the ideal mole fraction solubility at temperature T, Tf is the fusion temperature 
and ΔHf is the enthalpy of fusion. 
Along similar lines, in our studies we observe no correlation between the melting points 
of 3N/4N co-crystals and their corresponding solubility (Figures 3.13 and 3.14). This further 
proves the inadequacy of thermal properties for reliably predicting co-crystal solubility. 
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Figure 3.13 Melting point vs Solubility a) 3N:odd-chain diacid and b) 3N:even-chain diacid 
 
Figure 3.14 Melting point vs Solubility a) 4N:odd-chain diacid and b) 4N:even-chain diacid 
 
60 
 
 3.3.3 Correlation of solubility of the co-crystal and solubility of co-former 
Similar to the analysis conducted by Nair et al, our results show that with the increase in 
the solubility of the co-crystal former there is an increase in the solubility of co-crystal.
19
 Our 
data indicate a possible correlation between the co-crystal solubility and co-former solubility in 
all four sets of experiments, i.e. 3N:odd, 3N:even, 4N:odd and 4N:even, (Fig 3.15 and Fig 
3.16).  
 
 
Figure 3.15 Correlation of co-crystal and co-former solubility in a) 3N:odd system and b) 
3N:even system 
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Figure 3.16 Correlation of co-crystal and co-former solubility in a) 4N:odd system and b) 
4N:even system 
Our experimental data clearly demonstrates the ability to reliably alter the solubility of a 
given co-crystal based upon the solubility of the co-former. This provides a good pathway to 
fine-tune solubility in a systematic manner based upon the desired function.   
 3.3.4 Investigating the binding event in solution 
In solid state, the hydrogen-bonding patterns are well-defined; however in solutions the 
patterns are less-easily established. We used ITC to analyze the thermodynamic output that 
results from intermolecular interactions between our acceptors 3N/4N and donors SA/SeA in the 
solution state.  A concentrated solution of the acceptor was titrated into a dilute solution of the 
donor. During the first injection, most of the acceptor ligand interacts with the available donor 
acids in the solution. The interaction is exothermic as indicated by the nature of the curve in Fig 
3.17(a) (sample curve of 3N and succinic acid titration). With subsequent additions, the number 
of free available acid molecules reduces and hence the corresponding heat liberated also 
decreases exponentially. Towards the final injections, there are no more free acid available for 
binding which is reflected in the curve since no more heat is released. The heat resulting from 
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each individual injection is then integrated with respect to time and plotted against the molar ratio of 
the two components. These values are fitted using the independent model from the software 
NanoAnalyze to get output in terms of enthalpy change (ΔH), association constant (Ka) (Fig 3.17b). 
Since the acid and base combine in a 1:1 ratio (as seen in our crystal structure in Ch. 2), the 
stoichiometry (N) was fixed in the range of 0.9 to 1.1. To test the consistency of the data, another 
trial was performed under similar conditions. Table 3.6 displays the results of various 
thermodynamic parameters that were calculated using the equations, ΔG = -RTlnKa (to obtain the 
free energy change (ΔG) and ΔG = ΔH - TΔS; to obtain ΔS. 
 
Figure 3.17 a) ITC titration curve of 3N and succinic acid (b) Thermodynamic fit 
parameters. 
Table 3.6 Thermodynamic parameters based on ITC 
 3N:SA 4N:SA 3N:SeA 4N:SeA 
 #1 #2 #1 #2 #1 #2 #1 #2 
ΔG (kJ) -17.6 -17.2 -17.8 -17.9 -19.6 -19.7 -20.4 -20.5 
ΔH (kJ/mol) -14.1 -10.5 -8.6 -7.9 -3.2 -3.1 -9.9 -8.2 
ΔS (J/mol.K) 11.9 22.4 30.7 33.5 55.3 56.3 35.4 41.5 
  
A normal hydrogen bond enthalpy can range from anywhere between 10-65 kJ/mol.
22
  
The observed enthalpy in our system is a result of several factors that can be explained as 
follows; 
 In order for a heteromeric interaction to occur between the ligand and acid in solution 
phase, there are two processes that should be overcome, i.e. (i) the bonds between the acid 
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dimers in the solution must be broken and (ii) the water molecules surrounding the acid must be 
removed (de-solvation). Both these factors are endothermic and entropically favorable. In our 
ITC experiments, since very dilute acid solutions were used, most of the acid molecules would 
be present as monomers and thus the second process (de-solvation) will have a more significant 
effect on the resulting enthalpy. 
When new heteromeric hydrogen bond are formed between the free ligand and acid, it is 
an exothermic process and entropically unfavorable. The thermodynamic effects observed are the 
net effect of the breaking of old hydrogen bonds in homomeric dimer and formation of new 
hydrogen bonds in heteromeric dimers. In our system, the ligands under consideration are 
structurally similar (3N and 4N, Fig 3.5) and the diacids used only differ in the number of 
methylene groups between the two ends. Increased carbon chain length from succinic (C4) to 
sebacic (C10) contributes to increasing hydrophobicity in the system. Hence, since the binding 
events are very similar (acid-pyridine and acid-aminopyridine) we do not expect to see any 
significant differences in the overall free energy of the system, which is confirmed by the 
comparable ΔG values in the different combinations under study (Table 3.6). This proves that the 
face to face interaction at the hydrogen bonding site is similar in all cases and hence does not 
have any influence on the resulting solubility differences observed for the co-crystals. Thus, 
hydrophobicity of the acid co-former plays a crucial role in modulating the solubility of a given 
co-crystal. Increasing hydrophobicity of the acid chain length corresponds to decreasing 
solubility, which is exactly what we find in the previous section 3.2.3 in the form of a good 
reliable correlation between co-crystal solubility and co-former solubility.  
 3.4 Conclusions 
We have demonstrated a systematic way to alter the solubility of two API mimics using 
co-crystallizations. In some cases a higher solubility than the mimic was achieved (beneficial for 
pharmaceutical drugs with poor solubility issues), while in some cases the solubility was 
decreased (beneficial for slow release applications). It was found that melting point of the co-
crystal and its solubility cannot be correlated. ITC experiments show similar free energy values 
(ΔG) for different co-crystal combinations (including shortest and longest chain diacid used in 
this study) indicating that the binding interaction is very similar in all cases and does not 
contribute to the observed solubility differences. We successfully demonstrated a correlation 
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between the co-crystal solubility and co-former solubility. Higher hydrophobicity of the co-
former results in lower solubility of the co-crystal. Co-crystals thus offer a unique opportunity 
for developing new solid forms wherein the physical properties can be tuned in a predictable to 
give the desired result. 
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Chapter-4 Interdependence of structure and physical properties in 
co-crystals of azopyridines 
 4.1 Introduction 
Organized synthesis of supramolecular assemblies in the solid state provides a handle to 
design functional materials with desired physical properties. Physical properties like thermal 
stability, solubility and dissolution behavior can be tuned via co-crystallization process, and with 
supramolecular control over solid state architectures
1
, we can establish a correlation between 
properties and molecular structure in a predictable manner.
2
 For example, even-chain 
dicarboxylic acids like succinic (C4), adipic (C6), suberic (C8) and sebacic, (C10) form 1-D 
chains and structural consistency is observed in their crystal structures with an increase in the 
number of methylene groups from C4 to C10 (Fig 4.1).
3 
This consistency translates into a 
predictable structure-property relationship where the melting points decrease gradually with the 
increase in chain length of the diacids (Fig 4.2).  
 
Figure 4.1
3
 Structural consistency in even-chain dicarboxylic acid a) succinic
3a
, C4 b) 
adipic
3b
, C6 c) suberic
3c
, C8 d) sebacic acid
3d
, C10 
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Figure 4.2 A gradual decrease with an increase in the chain length among even-chain 
dicarboxylic acid 
 
Although stronger interactions drive the initial supramolecular assembly process, weaker 
intermolecular interactions play a crucial role in connecting discrete assemblies into 3-D solid-
state architectures.
4
 In our experiment we will highlight the influence of weaker secondary 
interactions in constructing assemblies of higher dimensionalities and also establish a possible 
structure-property correlation using co-crystallization techniques. For the experiment, we chose 
two pyridine-based isomeric acceptors, i.e. 3,3‟-azopyridine (3,3’-azpy) and 4,4‟-azopyridine  
(4,4’-azpy), Figure 4.3(a), and a set of four even chain aliphatic dicarboxylic acid; succinic, 
adipic, suberic and sebacic acid (with increasing number of carbon atoms in the backbone, Fig 
4.3(b)) as hydrogen bond donors. Co-crystals of 4,4’-azpy with succinic, adipic and sebacic acid 
were synthesized and reported previously by Wu et.al.
5
  We have completed the series by 
including the co-crystal of 4,4’-azpy with suberic acid. 
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Figure 4.3 a) binding site orientation in 3,3'-azopyridine (anti-parallel) and 4,4'-
azopyridine (co-linear); b) even chain dicarboxylic acid with increasing chain length 
 
 Molecular surface potential calculations using density functional theory (B3LYP, 6-
31G++G** basis set) method showed that the charges on the nitrogen atoms were -174 kJ/mol 
and -172 kJ/mol for 3,3’-azpy and 4,4’-azpy respectively (Fig 4.4). A difference of 2 kJ/mol is 
unlikely to be significant and should not play any role in influencing the structure directing 
processes. 
            
Figure 4.4 Surface potentials in 3,3'-azpy and 4,4'-azpy 
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However, the binding sites on the acceptors have a geometric bias, i.e. in 3,3’-azpy they 
are oriented in an anti-parallel fashion, whereas in 4,4’-azpy the binding sites are co-linear (Fig 
4.3). The primary molecular recognition occurs at the acid-pyridine interface forming robust and 
reliable COOH···N hydrogen bonds.  This key interaction will remain consistent in all crystal 
structures irrespective of the co-former chain length, but the secondary interactions will be 
greatly influenced by the chain length, increasing hydrophobicity of the acid donors and binding 
site orientation of the acceptors. We assume that infinite 1-D chains will be formed initially 
followed by their organization into 2-D sheets via weaker inter-chain interactions to give two 
different motifs (in phase and out of phase) in each of the two groups as postulated in Fig 4.5.  In 
motif 1 and 3 the chains are arranged in an out-of-phase fashion, while in motifs 2 and 4 they 
have an in-phase arrangement. 
     
Figure 4.5 Postulated motifs for the combination of 3,3'-and 4,4'-azopyridine with aliphatic 
diacids 
 Our objectives of the study are to seek answers to the following questions; 
i. Can we construct consistent and reliable assemblies in two groups of azopyridine 
co-crystals of dicarboxylic acids? 
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ii. Can we establish a reliable structure-property correlation in the given set of co-
crystals? 
iii. What is the effect of geometric bias on the overall molecular arrangement and 
physical property? 
 4.2 Experimental  
 4.2.1 Synthesis  
All chemicals, unless noted, were purchased from Sigma Aldrich and used without 
further purification.  Melting points were determined on a Fisher- Johns melting point apparatus. 
1
H and 
13
C NMR spectra were recorded on a Varian Unity plus 400 MHz or 200 MHz 
spectrometer in CDCl3 or D6-DMSO.  Infrared spectroscopy (IR) was done on a Nicolet 380 FT-
IR. 
4.2.1.1 Synthesis of 3,3’-azopyridine, (3,3’azpy)6 
The synthesis of 3,3’-azpy was carried out using a previously reported procedure.6  KOH 
(16.26g, 28.98mmol) was dissolved in 100ml of water and kept in an ice bath. Using a dropping 
funnel, bromine (5.24ml, 20.39mmol) was slowly added to the KOH solution with stirring, 
maintaining the temperature between 0-5 
º
C. After the addition was complete, 3-amino pyridine 
(1.9g, 20.18mmol) dissolved in 40ml of cold water was slowly added to it. The resulting mixture 
was stirred in an ice-bath for 1-2 h.  The solution was extracted into methylene chloride and the 
solvent was removed under reduced pressure. The resultant crude was subjected to column 
chromatography and the pure orange product was isolated in 46% yield. Mp 132-134 
º
C (lit. 136-
140 
º
C); 
1
H NMR (δH, 400MHz, CDCl3): 9.17 (d, 2H), 8.79 (s, 2H), 8.23 (d, 2H), 7.66 (t, 2H), 
appendix A. 
4.2.1.2 Synthesis of 4,4’-azopyridine,(4,4’-azpy)7 
The synthesis of 4,4’-azpy was carried out using a slightly modified procedure.7 4-Amino 
pyridine (2.50g, 26.55mmol) was dissolved in 20ml water and kept cold in an ice bath.  6% 
NaOCl (50ml, 36.25mmol diluted with 50ml water) was added drop wise to the pyridine solution 
with constant stirring while maintaining the temperature between 0-5 ºC. After stirring for 2-3 h 
in the ice-bath, the product was extracted into ether. After removing the solvent under reduced 
pressure, a small amount of hexane was added to the crude (to dissolve the product). Any 
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insoluble residue was discarded. The solvent was then removed under reduced pressure and pure 
bright-orange product was re-crystallized from methanol in 51% yield. Mp 106-109 ºC (lit.105-
106 ºC); 
1H NMR (δH, 400MHz, CDCl3): 8.88 (d, 4H), 7.76 (d, 4H), appendix A. 
 4.2.2 IR spectroscopy screening of co-crystals 
3,3’-azpy and 4,4’-azpy were screened with even-chain diacids using the solvent drop 
assisted grinding method. The acid and base were combined in 1:1 stoichiometry in a motor and 
pestle. A drop of methanol was added and the mixture was ground for 30 seconds. The resulting 
product was screened using IR spectroscopy to confirm co-crystal formation. All samples that 
showed a positive hit for co-crystal formation were then subjected to slow evaporation 
experiments to grow single crystals suitable for X-ray diffraction analysis.    
 4.2.3 Synthesis of co-crystals  
Stoichiometric amounts of the acid and base were dissolved in suitable organic solvents 
and the co-crystals were synthesized using slow evaporation method. The details of co-crystal 
synthesis are listed in Table 4.1.  
Table 4.1 Synthesis of 3,3'-and 4,4'-azopyridine co-crystals 
 4.3 Results 
We have structurally characterized five co-crystals, i.e. 3,3’-azpy:SA, 3,3’-azpy:AA, 
3,3’-azpy:SuA, 3,3’-azpy:SeA  and 4,4’-azpy:SuA. Crystal structures of 4,4’-azpy:SA5b, 4,4’-
Azopyridine:acid Abbreviation Mole 
ratio 
Solvent and 
method 
Condition Melting 
point 
(
º
C) 
3,3’-azopyridine: succinic acid 
 
3,3‟-azpy:SA 1:1 Ethanol- slow  
evaporation 
Ambient temp 
for 7 days 
144-146 
3,3’-azopyridine:adipic acid 
 
3,3‟-azpy:AA 1:1 Ethanol- slow  
evaporation 
Ambient temp 
for 14 days 
149-151 
3,3’-azopyridine:suberic acid 
 
3,3‟-azpy:SuA 1:1 Methanol-slow 
evaporation 
Ambient temp 
for 5 days 
133-136 
3,3’-azopyridine:sebacic acid 
 
3,3‟-azpy:SeA 1:1 Methanol-slow 
evaporation 
Ambient temp 
for 9 days 
122-125 
4,4’-azopyridine:succinic acid 
 
4,4‟-azpy:SA 1:1 Methanol-slow 
evaporation 
Ambient temp 
for 7 days 
205-209 
4,4’-azopyridine:adipic acid 
 
4,4‟-azpy:AA 1:1 Methanol-slow 
evaporation 
Ambient temp 
for 28 days 
189-192 
4,4’-azopyridine:suberic acid 
 
4,4‟-azpy:SuA 1:1 Ethanol-slow 
evaporation 
Ambient temp 
for 25 days 
160-163 
4,4’-azopyridine:sebacic acid 4,4‟-azpy:SeA 1:1 Methanol-slow 
evaporation 
Ambient temp 
for 12 days 
144-147 
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azpy:AA
5a
 and 4,4’-azpy:SeA5a were previously reported and their single crystal structures were 
characterized using XRD.
  
Table 4.2 lists the IR stretches for O-H···N hydrogen bonds and the 
C=O stretch in the acid and corresponding co-crystal. Detailed hydrogen bond geometries for 
3,3’-azpy and 4,4’-azpy co-crystals are listed in table 4.3. 
Table 4.2 IR spectroscopy C=O stretch and O-HN stretches in co-crystals of 3,3'-and 4,4'-
azopyridine 
Compound O-HN stretches (cm-1) Co-crystal 
C=O stretch (cm
-1
) 
Acid 
C=O stretch (cm
-1
) 
3,3’-azpy-SA 2480;1894 1704 1686 
3,3’-azpy-AA 2489;1876 1693 1683 
3,3’-azpy-SuA 2492;1888 1692 1684 
3,3’-azpy-SeA 2504;1887 1691 1682 
4,4’-azpy-SuA 2447;1894 1700 1684 
 
Table 4.3 Hydrogen bond geometries in co-crystals of 3,3'-and 4,4'-azopyridine 
Structure D-HA/Å D-H/Å HA/Å DA/Å D-HN/o 
3,3’-azpy:SA O(21)-H(21)...N(11) 0.946(15) 1.748(15) 2.6924(12) 176.5(13) 
3,3’azp:AA O(21)-H(21)...N(11) 0.913(17) 1.778(17) 2.6893(11) 176.5(15) 
3,3’-azpy:SuA O(21)-H(21)...N(11) 0.925(16) 1.756(16) 2.6798(11) 177.0(13) 
3,3’-azpy:SeA O(31)-H(31)...N(11) 
O(40)-H(40)...N(21)_#1 
1.04(3) 
1.08(3) 
1.65(3) 
1.61(3) 
2.682(3) 
2.683(3) 
175(2) 
171(2) 
4,4’-azpy:SuA O(21)-H(21)...N(11) 0.885(17) 1.809(18) 2.6633(13) 161.6(15) 
Symmetry code: #1 1+x, 1+y, 1+z 
 4.3.1 Structural characterization of co-crystals 
 4.3.1.1 Crystal structure of 3,3’-azpy:SA 
In the crystal structure of 3,3’-azpy:SA, the molecular recognition occurs at the expected 
acid-pyridine interface. Azopyridine interacts with succinic acid via O-H···N hydrogen bonds 
forming 1-D chains (Fig 4.6). The1-D chains run perpendicular to each other in the crystal lattice 
forming an interlocked network (Fig 4.7). These chains are connected via secondary C-
H(phenyl)···O(carbonyl) interactions between neighboring 1-D chains (Fig 4.8) 
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            Figure 4.6 1-D chain formed via O-H…N hydrogen bonds in 3,3'-azpy:SA co-crystal 
            
Figure 4.7 1-D chains running perpendicular to each other, green (azopyridine) and blue 
(succinic acid) 
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Figure 4.8 A top view of the weaker C-H···O (between phenyl and acid) interactions 
connecting neighboring perpendicular chains  
 4.3.1.2 Crystal structure of 3,3’-azpy:AA, 3,3’-azpy:SuA and 3,3’-azpy:SeA 
In the crystal structures of 3,3’-azpy:AA, 3,3’-azpy:SuA and 3,3’-azpy:SeA the primary 
mode of interaction between the acid and base is via O-H···N hydrogen bonds on either side of 
the diacid resulting in infinite 1-D chains. The chains then connect into 2-D planar sheets 
through auxiliary C-H(phenyl)···O(carbonyl) hydrogen bonds in neighboring chains and close contacts 
between azopyridine units (Fig 4.9). All three co-crystals show similar structure and arrangement 
in two dimensions.  
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Figure 4.9 2-D planar sheets in co-crystals of a) 3,3'-azpy:AA b) 3,3'-azpy:SuA and c) 3,3'-
azpy:SeA 
4.3.1.3 Crystal structure of 4,4’-azpy:SuA 
In the crystal structures of 4,4’-azpy:SuA,  O-HN interactions lead to infinite 1-D 
chains that are further organized into 2-D planar sheets via secondary C-HO interactions (Fig 
4.10). Two types of auxiliary C-HO interactions, i.e. C-H(phenyl)···O(carbonyl) and C-
H(phenyl)···O(hydroxyl)  connect the 1-D chains. Unlike in 3,3’-azpy co-crystals, there are no close 
contacts between neighboring azopyridine moieties. 
 
Figure 4.10 2-D planar sheet in 4.4'-azpy:SuA co-crystal 
4.3.2 Unit cell parameters of co-crystals 
The unit cell parameters of the co-crystals are listed in Table 4.4. 
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Table 4.4 Unit cell parameters of 3,3'-and 4,4'-azpy co-crystals 
Co-crystal 3,3’-azpy:SA 3,3’-azpy:AA 3,3’-azpy:SuA 3,3’-azpy:SeA 4,4’-azpy:SuA 
Crystal system Monoclinic Triclinic Triclinic Triclinic Triclinic 
Space group,  Z P21/c, 2 P-1, 1 P-1, 1 P-1, 2 P-1, 1 
a, Å 11.9092(7) 5.2025(4) 5.4680(6) 7.0388(14) 5.8269(6) 
b, Å 5.2342(3) 7.0703(6) 7.0381(7) 8.2451(18) 8.6817(8) 
c, Å 11.3589(7) 11.4579(10) 11.9358(12) 17.490(4) 9.0827(9) 
, ° 90.00 99.247(5) 98.867(6) 77.525(14) 76.314(6) 
, ° 91.198(3) 102.957(6) 93.592(6) 80.368(13) 87.963(6) 
, ° 90.00 101.395(5) 102.392(6) 85.474(14) 77.486(6) 
V, Å
3
 707.90(7) 393.25(6) 441.09(8) 976.1(3) 435.76(7) 
 
4.4 Discussion 
 4.4.1 Co-crystal vs salts 
In the pharmaceutical industry a pKa thumb rule is often used to predict the formation of a 
salt in acid-base reactions.
8
 It is generally accepted that a Δ pKa (pKa base- pKa acid) value > 2 or 
3 will result in a salt formation between the acid and base.
9
 An extension to this rule was recently 
proposed by Nangia et al.
10
 for co-crystal systems with a series of carboxylic acids and pyridine 
based bases. According to their analysis, a negative pKa difference between the interacting 
species will always result in the formation of co-crystals, as opposed to salts. Another highlight 
of the study was the observation that when the Δ pKa is between 0-3, the accurate prediction of 
neutral or ionic synthons in the solid state is not possible.
11
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A pKa analysis of our acid-base system gives us a negative Δ pKa value for all five 
combinations of azopyridine and the diacids (Table 4.5)
12
. Thus one can reliably predict a neutral 
acid-pyridine heterosynthon to be formed between azopyridine and corresponding diacids as 
opposed to an ionic one (Fig 4.11). As previously discussed in Chapter 2, we can distinguish 
between neutral O-H···N and ionic O
-
···H-N
+
 charge assisted interactions by analyzing 
structural parameters such as the acid C-O bond distances in the resulting single crystal structure 
and the endocyclic C-N-C bond angle which is sensitive to protonation.  
Table 4.5 pKa values of components in 3,3'-and 4,4'-azpy cocrystals
12
 
Co-crystal pKa (acid) pKa (base) Δ pKa 
3,3’-azpy:SA 4.24 3.76 -0.48 
3,3’-azpy:AA 4.39 3.76 -0.57 
3,3’-azpy:SuA 4.46 3.76 -0.7 
3,3’-azpy:SeA 4.48 3.76 -0.72 
4,4’-azpy:SuA 4.46 1.93 -2.53 
 
 
Figure 4.11 Neutral and charged assisted heterosynthons between acid-pyridine pair 
 4.4.1.1 Characterization using IR spectroscopy 
In our set of experiments we have obtained 5/5 co-crystals, i.e. 100% co-crystallization 
success. The co-crystals were first screened using IR spectroscopy. Co-crystal formation was 
confirmed by i) two broad stretches in the 1800-2500 cm
-1
 region, representing the 
intermolecular O-H···N hydrogen bond and ii) C=O stretch, which in all cases was above 1670 
cm
-1
 (Table 4.2) indicating the presence of neutral carboxylic acid moiety, (Figure 4.12). 
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Figure 4.12 IR spectra of 3,3'-azpy (above) and 3,3'-azpy:SA (below) 
 4.4.1.2 Characterization using structural parameters 
Structural parameters of the ancillary groups like C-N-C endocyclic bond angle and C-O 
bond distances in the carboxylic acid can be used to interpret the neutral or ionic nature of an 
acid-pyridine heterosynthon. The C-O (short) bond distances in our crystal structures range from 
1. 204- 1.218 Å and C-O (long) bond distances range from 1.313-1.339 Å, while the C-N-C bond 
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angles range between 117.4°- 118.7°. With reference to Fig 2.21, our bond distance and angle 
values indicate that a neutral heterosynthon is formed in all five crystal structures. 
 4.4.2 Examination of the motifs and packing pattern in the crystal structures 
In all five crystal structures, the primary synthon formed is the acid-pyridine 
heterosynthon via neutral O-H···N hydrogen bonds. The resulting architecture is 1-D chain, 
which extends into 2-D layered structure via weaker (py)C-H···O(acid) intra-layer interactions. 
Although the final outcome in all crystal structures is 2-D sheets, there is however a basic 
difference in the way 1-D chains are arranged with respect to each other to form the extended 2-
D architecture. 
 4.4.2.1 3,3’-Azopyridine co-crystal structures 
In 3,3’-azpy:AA, 3,3’-azpy:SuA and 3,3’-azpy:SeA individual 1-D chains are organized 
into 2-D planar sheets in an in-phase arrangement, motif 4  (Fig 4.5 and 4.9). The chains are 
connected via C-H(phenyl)···O(carbonyl) interactions. Short contacts between the azopyridine 
moieties are also observed in all three crystal structures within the plane of each layer. 
In 3,3’-azpy:AA (Fig 4.13a),  the packing between individual sheets result in inter-layer 
short contacts between (acid)C-H···C(py) and (acid)C-H···O(acid). In 3,3’-azpy:SuA (Fig 4.13b), the 
layers are stacked one above the other using not only  (acid)C-H···O(acid) interactions but also Π-Π 
interactions between azopyridine molecules. In 3,3’-azpy: SeA (Fig 4.13c), there are alternating 
interlayer (acid)C-H···O(acid) and Π-Π interactions.  
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     Figure 4.13 Packing of 2-D sheets in a) 3,3'-azpy: AA b) 3,3'-azpy:SuA and c) 3,3'-
azpy:SeA 
In 3,3’-azpy:SA, the packing is very different. An unexpected motif is observed with two 
types of 1-D chains that run perpendicular to each other and result in a 3-D interlocked network. 
The crystal structure lacks close packing between individual chains as observed in other three co-
crystals of 3,3’-azpy (Fig 4.7 and 4.8).  
 4.4.2.2 4,4’-azopyridine co-crystal structures 
In the crystal structures of 4,4’-azpy:SA5b, 4,4’- AA5a and 4,4’-azpy:SuA,  motif 1 exists 
with the 1-D chains arranged in an out of phase pattern with respect to each other forming 2-D 
sheets (Fig 4.5, 4.10 and 4.14).  
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          Figure 4.14 2-D sheets in a) 4,4'-azpy:SA and b) 4,4'-azpy:AA co-crystals
5 
 
In 4,4’-azpy:SA the 2-D layers are stacked via interlayer (py)C-H···O(acid) and Π-Π 
interactions between neighboring layers. In 4,4’-azpy:AA and 4,4’-azpy:SuA only (acid)C-
H···C(py)  contacts are used to connect the layers (Fig 4.15). 
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Figure 4.15 Packing of 2-D sheets in a) 44,'-azpy:SA; b) 4,4'-azpy:AA and c) 4,4'-azpy:SuA 
 
The crystal structure of 4,4’-azpy:SeA displays motif 2, where chains are organized in an 
in-phase arrangement to form planar 2-D layers (Figs 4.5 and 4.16). The 2-D layers are then 
packed via (acid)C-H···C(py) interactions (Fig 4.17). 
 
Figure 4.16 2-D sheet in 4,4'-azpy:SeA co-crystal 
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Figure 4.17 Packing pattern of 2-D sheets in 4,4'-azpy:SeA co-crystal 
 
Thus an analysis of all eight crystal structures of 3,3‟-and 4,4‟-azopyridine co-crystals gives the 
following distribution of motifs (Fig 4.18); 
 
Figure 4.18 Distribution of motifs observed in our crystal structures 
 4.4.3 Analysis of thermal behavior of co-crystals 
Melting point of solids is an important physical property that can have implications for 
different applications and most importantly for processing, shelf-life and storage purposes.
13
 The 
physical properties of bulk solids depend by and large on the solid-state structure and packing 
arrangement in the crystal lattice. If we can successfully prove that thermal behavior and 
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molecular structure are interrelated, then simple co-crystallization techniques can be used as a 
means of modulating the thermal behavior of bulk solids in a reliable manner. 
 4.4.3.1 Correlating thermal behavior as a function of acid chain length 
In 4,4’-azpy co-crystals with succinic (C4), adipic (C6), suberic (C8) and sebacic (C10) 
acid, structural consistency is maintained as we systematically increase the carbon chain length 
in the diacids from C4 to C10. Although in 4,4’-azpy:SeA, motif 2 is observed instead of motif 1 
(observed in all other cases), the packing pattern is similar in all four cases, i.e. the 1-D chains 
are closely arranged into 2-D layers using weaker intra-layer interactions (Fig 4.10, 4.14 and 
4.15) followed by 2-D layers via weaker inter-layer interactions (Figs 4.16 and 4.17). This 
consistency in the crystal structure is reflected in their melting points (Table 4.1). In a plot of 
4,4’-azpy co-crystal melting points against the carbon chain length in the corresponding diacids, 
a near-linear correlation is observed which indicates reliable structure-property interdependence 
(Figure 4.19).   
 
Figure 4.19 Melting point of 4,4'-azpy co-crystals as a function of carbon chain length 
 
In 3,3’-azpy co-crystals motif 4 was observed in 3/4 cases, where 1-D chains were 
arranged into 2-D layers via intra-layers interactions (Fig 4.9), followed by their close packing 
(Fig 4.13), thus maintaining structural consistency in 3,3’-azpy:AA, SuA and SeA co-crystals.  
The outlier 3,3’-azpy:SA displays an unexpected motif with a very different packing of 1-D 
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chains (Fig 4.7 and 4.8). This discrepancy in the crystal structure is also reflected in its melting 
point which is lower than in the other solids (Fig 4.20). 
 
Figure 4.20 Melting point of 3,3'-azpy co-crystals as a function of carbon chain length 
 4.4.3.2 Effect of binding site geometrical bias on melting point 
The position of the binding site on the co-crystallizing agent plays an important role in 
arranging the building blocks during the assembly process. Any alteration in the relative 
orientation is reflected in differences in packing and overall assembly in solid-state. Changes in 
the solid-state structure will also bring about variations in the bulk physical properties.  
In our experiments, the two acceptors have their binding sites oriented at different angles 
with respect to each to other. Although this does not affect the primary molecular recognition 
event forming 1-D chains, the packing pattern of the resulting 1-D chains is very different across 
the group. The two classes of co-crystals display very different melting points with respect to the 
diacids themselves. 3,3’-azpy co-crystals have melting points lower than the diacids, whereas 
4,4’-azpy co-crystals have melting points higher than those of the diacids (Fig 4.21).  
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Figure 4.21 Melting point correlation between 3,3'-and 4,4'-azopy co-crystals and molecular 
structure of diacids 
In order to provide a reasonable explanation for the observed trend in melting points 
between the two classes of co-crystals, we tried to examine their packing co-efficient values 
using Olex v 2.1 (Table 4.6). However, the packing co-efficients of the two classes of co-crystals 
fall within the range of 61-69% and do not display any correlation to the observed melting point 
behavior. 
Table 4.6 Packing co-efficients of 3,3'-and 4,4'-azpy co-crystals 
 SA AA SuA SeA 
3,3’azpy  64% 66% 65% 65% 
4,4’-azpy  64% 66% 69% 61% 
 
The observed differences in the melting point of 3,3‟-and 4,4‟-azopyridine co-crystals 
can be attributed to the variation in packing arrangement due to the differences in the orientation 
of binding sites on the acceptor molecules. This argument can be supported by the work done by 
Braga et al. where the co-crystals of dicarboxylic acids (adipic, suberic and sebacic acid) with 
1,2-bis- (4-pyridyl)ethane (BPA) displayed  higher melting points than the corresponding diacids 
whereas co-crystals with 1,2-bis(4-pyridyl)propane (BPP) displayed lower melting points than 
the corresponding diacids. Since the same set of diacids was used, the difference observed can be 
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attributed to the difference in packing arrangements caused as a result of the binding site biased 
in BPA and BPP (Fig 4.22).
2 
 
Figure 4.22 Schematic of BPA and BPP 
 4.5 Conclusion 
We have synthesized two isomeric pyridine based acceptors 3,3‟-and 4,4‟-azopyridine 
with even chain diacids and demonstrated the following; 
1) Reliable and consistent assemblies can be produced in both groups of azopyridine co-
crystals of dicarboxylic acid. 
2) Based on our crystal structure and thermal behavior analysis, a reliable structure-
property correlation is established within a given series as long as structural 
consistency is maintained. Any deviation from this is reflected in the thermal 
behavior.  
3) The position of the binding site plays a key role in directing the overall assembly 
formation and hence the bulk physical property like melting point.
14
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Chapter-5 Competing hydrogen-bond and halogen-bond donors in 
crystal engineering 
 5.1 Introduction 
The hydrogen bond is by far the most commonly used synthetic tool for engineering 
molecular solids.
1
 Hydrogen-bonded synthons such as acid···pyridine
2
, phenol···pyridine
2
, 
oxime···N(heterocycle)
3
 have been explored and are considered as reliable and robust synthons in 
crystal engineering (Fig 5.1).  
 
Figure 5.1 Hydrogen bonded heterosynthons a) acid-pyridine b) phenol-pyridine and c) 
oxime-pyridine 
 
Recently halogen bonds
4
 have been explored extensively for its use as „supramolecular 
glue‟ in crystal engineering. Halogen bonding is a non-covalent interaction between a covalently 
bonded halogen atom (X) and Lewis base (A). The halogen bonding interaction is linear (D-
X···A) and parallels the behavior observed in hydrogen bonds.
5
 Halogen-bond distances are 
markedly shorter than the sum of their van der Waals radii, and the shorter the X···A distance, 
stronger the interaction.
6
 The interaction energies of halogen bonds are in the range of 5-180 kJ 
mol
-1 
(the strong interaction I2I
- 
in I3
- 
is the extreme)
7,8
, while the energy for hydrogen-bond 
interactions falls in the range of 10-65 kJ mol
-1
.
9
 The halogen bonds thus show energetic and 
geometric trends that are comparable to hydrogen bonds. A halogen bond is typically a single 
point interaction and is less sensitive to the pka of a given system. For example, many hydrogen- 
bond donors can undergo a proton transfer if the donor molecule has strong electron withdrawing 
groups
10
 thus resulting in a salt formation instead of a co-crystal. A halogen atom (I or Br) is 
typically “activated” by introducing a fluorinated backbone11 or used in its acetylated form12, 
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both of which increase the positive charge at the tip of the halogen atom making them more 
powerful electron acceptors. As an example, Fig 5.2 shows an increasing positive charge on 
iodine atom in activated tetrafluoroiodo benzene (+220kJ/mol) and iodoethynyl benzene 
(+250kJ/mol) as compared to non-activated iodobenzene (+111kJ/mol).
13
 
 
Figure 5.2 Charges on iodine atoms in activated and non-activated halogen-bond donors 
(generated using molecular surface potential calculations) 
 
Since hydrogen bonds and halogen bonds have comparable features, it is very likely that 
they can compete in a supramolecular synthesis. Several studies have demonstrated the potential 
of pyridine based molecules to interact with hydrogen bond donors like acid, phenol and oxime 
as well as halogen bond donors like iodine and bromine. A CSD search was conducted on co-
crystals by limiting the search parameters to aromatic acid, phenol, oxime, iodo and bromo 
benzenes (as donors) with pyridine type compounds (as acceptors). We found several examples 
in the CSD that have explored the interaction of pyridine type heterocycles with hydrogen bond 
donors (HB) (823 hits) and halogen bond donors (XB) (132 hits) individually (Fig 5.3). In our 
experiments we will combine the two donors on one single backbone and thus investigate the 
competition and structure directing balance between HBs and XBs. 
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Figure 5.3 Number of hits in the CSD of pyridine based co-crystals with HB and XB donors 
 
In our study we wish to investigate the following; 
1. Competition between HB and XB donors for the pyridine nitrogen atom. 
2. Influence of geometric bias of the acceptors on the competition and final assembly. 
3. Participation of auxiliary acceptors like carbonyl „O‟, hydroxyl „O‟ and azo „N‟ in 
interacting with the donors. 
 
 We have employed six bi-functional donor molecules equipped with one HB and one XB 
on the same backbone; 4-iodotetrafluorobenzoic acid (COOH-I), 4-bromotetrafluorobenzoic 
acid (COOH-Br), 4-iodotetrafluoro phenol (OH-I), 4-bromotetrafluoro phenol (OH-Br), 4-
iodotetrafluoro oxime (Ox-I) and 4-bromotetrafluoro oxime (Ox-Br) (Fig 5.4). These molecules 
were co-crystallized with two symmetric acceptors 3,3‟-azopyridine (3,3’-azpy) and 4,4‟-
azopyridine (4,4’-azpy) (Fig 5.4). 
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Figure 5.4 Bi-functional donors and symmetric acceptors 
 
Electrostatic charges play an important role in directing the molecular recognition event 
between interacting building blocks. The best electron donor (highest negative potential) will 
preferentially pick up the best electron acceptor (highest positive potential) in the given 
supramolecular system.
14
 However in our study, the target acceptors are symmetrical and thus 
are electrostatically unbiased but geometrically biased as seen previously in Chapter 4, Fig 4.4. 
In 3,3’-azpy the binding sites are oriented anti-parallel with respect to each other, while in 4,4’-
azpy they are co-linear (Fig 5.4). With two types of donor atoms (HB and XB) and one most 
basic acceptor atom („N‟) in our system, there are three different possible outcomes of a 1:1 
combination of the azopyridines and the bi-functional donors (Fig 5.5). 
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Figure 5.5 Postulated outcomes 
 5.2 Experimental  
 5.2.1 Synthesis of ligands 
All chemicals, unless noted, were purchased from Sigma Aldrich and used without 
further purification.  Melting points were determined on a Fisher- Johns melting point apparatus. 
1
H and 
13
C NMR spectra were recorded on a Varian Unity plus 400 MHz or 200 MHz 
spectrometer in CDCl3 or D6-DMSO. 
 5.2.1.1 Synthesis of 3,3’-and 4,4’-azopyridine6,7 
See Chapter 4, section 4.2.1. 
 5.2.1.2 Synthesis of bi-functional donors15 
The bi-functional donors were synthesized by Prashant Chopade.
15  
 
 5.2.2 Synthesis of co-crystals 
Stoichiometric amounts of the donor and acceptor were dissolved in suitable organic 
solvents and co-crystals were grown using slow evaporation, Table 5.1 
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Table 5.1 Synthesis of 3,3'-and 4,4'-azopyridine co-crystals 
Acceptors Donors Co-crystal 
abbreviation 
Mole 
ratio 
Solvent Melting 
points 
º
C 
3,3’-
azopyridine 
4-iodotetrafluorobenzoic acid 3,3‟-azpy:COOH-I 1:1 Ethanol 182-185 
4-bromotetrafluorobenzoic acid 3,3‟-azpy:COOH-Br 1:1 Ethanol 155-157 
4-iodotetrafluorophenol 3,3‟-azpy:OH-I 1:1 Ethanol 125-127 
4-bromotetrafluorophenol 3,3‟-azpy:OH-Br 1:1 Ethanol 170-173 
4-iodotetrafluoroaldoxime 3,3‟-azpy:Ox-I 1:1 Ethanol 145-148 
4-bromotetrafluoroaldoxime 3,3‟-azpy:Ox-Br 1:1 Ethanol 105-108 
      
4,4’-
azopyridine 
4-iodotetrafluorobenzoic acid 4,4‟-azpy:COOH-I 1:1 Ethanol 220-222 
4-bromotetrafluorobenzoic acid 4,4‟-azpy:COOH-Br 1:1 Ethanol 190-191 
4-iodotetrafluorophenol 4,4‟-azpy:OH-I 1:1 Ethanol 163-165 
4-bromotetrafluorophenol 4,4‟-azpy:OH-Br 1:1 Ethanol 133-136 
4-iodotetrafluoroaldoxime 4,4‟-azpy:Ox-I 1:1 Ethanol 115-116 
4-bromotetrafluoroaldoxime 4,4‟-azpy:Ox-Br 1:1 Ethanol 125-126 
 
 5.3 Results 
We have obtained crystal structures of twelve co-crystals of 3,3‟-and 4,4‟-azopyridine 
with six bi-functional donors each. The hydrogen-bond and halogen-bond geometries of all 12 
structures are listed in Tables 5.2 and 5.3, respectively. 
Table 5.2 Hydrogen-bond geometries in co-crystals of 3,3'-and 4,4'-azopyridine 
Structure D–H…A/Å D–H/Å HA/Å DA/Å D–HN/° 
3,3’-azpy:COOH-I N(11)-H(11)O(21A)_#1 1.22(2) 1.32(2) 2.536(2) 174(2) 
 
3,3’-azpy:COOH-Br O(21)-H(21)N(11)_#1 1.14(3) 1.41(3) 2.549(2) 177(3) 
3,3’-azpy:OH-I O(21)-H(21)N(11)_#1 0.90(2) 1.75(2) 2.6162(15) 159(2) 
3,3’-azpy:OH-Br O(31)-H(31)N(11) 
O(41)-H(41)N(21) 
0.88(2) 
0.88(2) 
1.77(2) 
1.73(2) 
2.6224(16) 
2.5963(15) 
163.2(18) 
166.8(18) 
    
3,3’-azpy:Ox-I O(27)-H(27)N(27)_#1_#2 0.72(2) 2.18(2) 2.8460(17) 153(2) 
3,3’-azpy:Ox-Br O(17)-H(17)N(21)_#1 0.76(4) 1.95(4) 2.708(3) 178(4) 
4,4’-azpy:COOH-I N(11)-H(11)O(31B)_#1 0.88 
0.88 
1.75 
1.73 
2.605(9) 
2.598(6) 
164.3 
167.5 
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4,4’-azpy:COOH-Br O31A1-H31A1N11A1 
O31B1-H31B1N21B1_#1 
O31A2-H31A2N11A2 
O31B2-H31B2N21B2_#2 
0.84 
0.84 
0.84 
0.84 
1.76 
1.84 
1.75 
1.83 
2.566(10) 
2.67(3) 
2.587(9) 
2.67(4) 
158.8 
167.6 
170.0 
175.3 
4,4’-azpy:OH-I O(31)-H(31)N(11) 0.84 1.84 2.614(4) 152.3 
 
4,4’-azpy:OH-Br O(31)-H(31)N(11) 0.83(2)  1.86(2) 2.6342(16) 155(2) 
4,4’-azpy:Ox-I O(37)-H(37)N(11) 0.82(2) 1.90(2) 2.7052(19) 169(2) 
 
4,4’-azpy:Ox-Br O(27)-H(27)N(11)_#1 0.94(6) 1.79(6) 2.704(6) 162(6) 
 
Symmetry codes: 3,3‟-azpy:COOH-I  #1 -x-1,-y,-z+2. 3,3‟-azpy:COOH-Br  #1 -x+2,-y+1,-z.   3,3‟-azpy:OH-I  #1 -x+1,-y+1,-z+1. 3,3‟-azpy:Ox-
I  #1 -x,-y,-z+2  #2 -x+3,-y+1,-z.  3,3‟-azpy:Ox-Br #1 -x,-y,-z-1. 4,4‟-azpy:COOH-I  #1 x+2,y-2,z+1. 4,4‟-azpy:COOH-Br #1 x-1,y+1,z+1    #2 
x+2,y+1,z+1.  4,4‟-azpy:Ox-Br #1 -x+2,-y+3,-z+1       
 
Table 5.3 Halogen-bond geometries in co-crystals of 3,3'-and 4,4'-azopyridine 
Structure C-XA XA/Å C-XA/° 
3,3’-azpy:COOH-I C-(24A)-I(1)O(22A)_#2 2.8694(13) 170.66(6) 
 
3,3’-azpy:COOH-Br C-(24)-Br(1)O(22)_#2 2.8792(17) 
 
172.23(7) 
3,3’-azpy:OH-I C(24)-I(1)O(21)_#2  
 
3.0913(10) 156.81(4) 
3,3’-azpy:OH-Br C(34)-Br(1)O(31)_#1 
C(44)-Br(2) O(41)_#2 
 
3.1138(11) 
3.0750(10) 
156.32(5) 
158.68(5) 
3,3’-azpy:Ox-I C(24)-I(1)N(11) 2.8279(12) 174.75(4) 
 
3,3’-azpy:Ox-Br C(14)-Br(1)O(17)_#1 3.0557(19) 158.49(9) 
 
4,4’-azpy:COOH-I C(34A)-I(1A) N(21)_#1 2.796(5) 173.4(3) 
 
4,4’-azpy:COOH-Br C(34A1)-Br(1A1)N(21A1)_#1 2.802(7) 176.9(4) 
 
4,4’-azpy:OH-I C(34)-I(1)N(21)_#1 2.960(3) 165.98(11) 
 
4,4’-azpy:OH-Br C(34)-Br(1)N(21)_#1 2.9717(12) 165.95(5) 
 
4,4’-azpy:Ox-I C(34)-I(1)N(21)_#1 2.8200(15) 178.38(5) 
 
4,4’-azpy:Ox-Br C(24)-Br(1)N(14)_#1 3.395(4) 171.94(17) 
Symmetry codes  3,3‟-azpy:COOH-I  #2 x+1,-y+1/2,z-1/2. 3,3‟-azpy:COOH-Br  #2 x-1,-y+1/2,z+1/2.  3,3‟-azpy:OH-I #2 -x+1/2,y-1/2,-z+3/2.  
3,3‟-azpy:OH-Br  #1 -x+1,y-1/2,-z+1/2    #2 -x,y+1/2,-z+3/2. 3,3‟-azpy:Ox-Br #1 x,y+1,z+1. 4,4‟-azpy:COOH-I  #1 x-2,y+2,z-1. 4,4‟-
azpy:COOH-Br  #1 x-1,y+1,z+1. 4,4‟-azpy:OH-I  #1 x-2,y+1,z+1. 4,4‟-azpy:OH-Br #1 x+2,y-1,z-1. 4,4‟-azpy:Ox-I  #1 x-1/2,-y-1/2,z+1/2. 4,4‟-
azpy:Ox-Br #1 x-1/2,-y+3/2,z-1/2.       
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 5.3.1 Description of the crystal structures 
 5.3.1.1 Co-crystals of 3,3’-azopyridine 
 5.3.1.1.1 3,3’-Azopyridine:4-iodotetrafluorobenzoic acid; 3,3’-azpy:COOH-I 
In a reaction between 3,3’-azpy and 4-iodotetrafluorobenzoic acid, the primary 
recognition occurs between the acid and pyridine moiety via O-H···N hydrogen bonds forming a 
trimer (Fig 5.6). The positive tip of the iodine atom interacts with a lone pair on a carbonyl 
oxygen atom with I···O halogen bonds, thus connecting individual trimers and extending the 
architecture along two dimensions (Fig 5.7). 
 
Figure 5.6 Trimer formed via acid...pyridine heterosynthon in 3,3'-azpy:COOH-I (The 
apparent ‘covalent’ bond between COOH and py is due to a disorder over two positions of the 
haloacid). 
 
Figure 5.7 2-D network formed via O-H…N(py) and C-I…O interactions in 3,3‟-
azpy:COOH-I co-crystal. 
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 5.3.1.1.2 3,3’-Azopyridine:4-bromotetrafluorobenzoic acid; 3,3’-azpy:COOH-Br 
Similar to the previous crystal structure, in 3,3’-azpy:COOH-Br acid-pyridine 
interactions produce the primary trimers followed by their extension into 2-D sheets via weaker 
C-Br···O interactions (Fig 5.8).  
 
Figure 5.8 3,3‟-azpy:COOH-Br co-crystal showing primary O-H…N(py) and secondary C-
Br…O interactions 
 5.3.1.1.3 3,3’-Azopyridine:4-iodotetrafluorophenol; 3,3’-azpy:OH-I 
Of the two potential single point donor atoms („OH‟ and „I‟) in 4-iodotetrafluorophenol, 
both pyridine site on the acceptor picks up the hydroxyl hydrogen atom forming an O-H···N 
heterosynthon. The trimers are then connected into 2-D layers via intra-layer C-I···O interactions 
(Fig 5.9). 
 
Figure 5.9 3,3‟-azpy:OH-I crystal structure showing primary O-H…N(py) and secondary C-
I…O interactions forming 2-D layer. 
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 5.3.1.1.4 3,3’-Azopyridine:4-bromotetrafluorophenol; 3,3’-azpy:OH-Br 
In the 3,3’-azpy:OH-Br co-crystal, intermolecular O-H···N hydrogen bonds produce 
trimeric supermolecules. These individual supermolecules then assemble into 2-D layers via C-
Br···O interactions (Fig 5.10). 
 
Figure 5.10 3,3‟-azpy:OH-Br crystal structure showing intermolecular O-H…N(py) and C-
Br…O interactions. 
 5.3.1.1.5 3,3’-Azopyridine:4-iodotetrafluorooxime; 3,3’-azpy:Ox-I 
The crystal structure of 3,3’-azpy:Ox-I is different from the other co-crystals of 3,3‟-
azpy in this study. In 3,3’-azpy:Ox-I, the two pyridine nitrogen atoms on azopyridine picks up a 
iodine atom to form C-I···N halogen bonds. The oxime group engages in a homomeric dimer, 
thus resulting in a 1-D infinite chain like assembly (Fig 5.11).  
 
Figure 5.11 3,3’-azpy:Ox-I co-crystal with oxime-oxime dimer and C-I…N(py) halogen 
bonds forming 1-D corrugated chain 
 5.3.1.1.6  3,3’-Azopyridine:4-bromotetrafluorooxime; 3,3’-azpy:Ox-Br 
In 3,3’-azpy:Ox-Br crystal structure, a trimer is produced via O-H···N hydrogen bonds, 
followed by their assembly into 2-D layers via secondary C-Br···O interactions (Fig 5.12). 
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Unlike in the case of 3,3’-azpy:Ox-I, where the oxime engages in a homomeric dimer, in this 
case the oxime is a part of the primary structure directing force.  
 
Figure 5.12 3,3‟-azpy:Ox-Br crystal structure showing O-H…N(py) primary hydrogen 
bonds and secondary C-Br…O interactions 
 5.3.1.2 Co-crystals of 4,4’-azopyridine 
 5.3.1.2.1 4,4’-Azopyridine:4-iodotetrafluorobenzoic acid; 4,4’-azpy:COOH-I 
In the crystal structure of 4,4’-azpy:COOH-I, the primary recognition event occurs 
between acid-pyridine (O-H···N hydrogen bonds) and I-pyridine (C-I···N halogen bonds) in 
parallel. The resulting assembly is an infinite 1-D chain (Fig 5.13). 
 
Figure 5.13 1-D infinite chain in 4,4‟-azpy:COOH-I co-crystal formed via O-H…N(py) and 
C-I…N(py) hydrogen and halogen bond, respectively. 
 5.3.1.2.2 4,4’-Azopyridine:4-bromotetrafluorobenzoic acid; 4,4’-azpy:COOH-Br 
Similar to the previous structure, 4,4’-azpy:COOH-Br displays a 1-D chain architecture 
formed via both hydrogen bond (O-H···N) as well as halogen bonds (C-Br···N), (Fig 5.14). 
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Figure 5.14 4,4‟-azpy:COOH-Br co-crystal showing O-H…N(py) hydrogen bonds and C-
Br…N(py) halogen bond interactions 
 5.3.1.2.3 4,4’-Azopyridine:4-iodotetrafluorophenol; 4,4’-azpy:OH-I 
The crystal structure of 4,4’-azpy:OH-I displays a 1-D chain formed from O-H···N 
hydrogen bonds as well as C-I···N halogen bonds on either sides of the azopyridine (Fig 5.15). 
 
Figure 5.15 4,4‟-azpy:OH-I crystal structure indicating 1-D chains formed via both O-
H…N(py) and C-I…N(py) primary interactions 
 5.3.1.2.4 4,4’-Azopyridine:4-iodotetrafluorophenol; 4,4’-azpy:OH-Br 
4,4’-azpy:OH-Br co-crystal displays a 1-D chain formed via hydrogen bonds (O-H···N) 
and halogen bonds (C-Br··· N)(Fig 5.16). 
 
Figure 5.16 4,4‟-azpy:OH-Br co-crystal structure showing 1-D chain formed via both 
hydrogen (O-H…N(py)) and halogen (C-Br…N(py)) bonds 
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 5.3.1.2.5 4,4’-Azopyridine:4-iodotetrafluorophenol; 4,4’-azpy:Ox-I 
In the crystal structure of 4,4’-azpy:Ox-I, the primary recognition events occur between 
oxime-pyridine (O-H···N hydrogen bonds) and I-pyridine (C-I···N halogen bonds) in parallel. 
The resulting assembly is an infinite 1-D chain (Fig 5.17). No oxime-oxime dimers are observed 
in this case. 
 
Figure 5.17 4,4‟-Azpy:Ox-I crystal structure with primary C-I…N(py) and O-H…N(py) 
interactions forming 1-D chain 
 5.3.1.2.6 4,4’-Azopyridine:4-iodotetrafluorophenol; 4,4’-azpy:Ox-Br 
When iodine is replaced by bromine in 4,4’-azpy:Ox-Br, the resulting assembly is very 
different. The primary recognition occurs at the oxime-pyridine interface forming 1-D assembly. 
Interestingly the free bromine atom interacts with an azo nitrogen atom (despite the presence of 
other secondary, and better, acceptors like oxygen or nitrogen atoms of the oxime in the system) 
(Fig 5.18). This interaction runs perpendicular to the 1-D chain resulting in an interlocked 3-D 
network (Fig 5.19).  
 
Figure 5.18 4,4‟-azpy:Ox-Br crystal structure with primary O-H…N(py) hydrogen bonds 
and secondary C-Br…N(azo) interactions 
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Figure 5.19 3D-architecture in 4,4‟azpy:OxBr co-crystal 
 5.4 Discussion 
In order to study the structure-directing influence and the competition between hydrogen 
bond (acid, phenol, oxime) and halogen bond (I, Br) donors with an electrostatically unbiased 
but geometrically biased system, we set up a total of twelve co-crystallization experiments. We 
obtained 100% supramolecular yield, each combination produced a co-crystal and analysis of all 
twelve crystal structures showed that both hydrogen and halogen bond donors actively 
participated in the assembly process either via primary or secondary interactions. A map of the 
structural landscape is displayed in Table 5.4 and Fig 5.20. 
Table 5.4 Summary of the structural outcome in 3,3’-and 4,4’-azobipyridine co-crystals of 
bi-functional donors. 
 COOH-I 
(acid-H) 
COOH-Br 
(acid-H) 
OH-I 
(phenol-H) 
OH-Br 
(phenol-H) 
Ox-I 
(oxime-H) 
Ox-Br 
(oxime-H) 
 
3,3’- azpy 
 
OH  > I 
 
A 
 
OH  > Br 
 
A 
 
OH  > I  
 
         A 
 
OH > Br 
 
A 
 
OHox < I 
 
C 
 
OHox > Br 
 
A 
 
 
4,4’- azpy 
 
OH = I 
 
B 
 
OH = Br 
 
B 
 
OH = I  
 
B 
 
 
OH = Br 
 
B 
 
OHox = I 
 
B 
 
OHox > Br 
 
A 
A: HB>XB, B: HB=XB, C: HB<XB 
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Figure 5.20 Summary of the outcome in 3,3’-and 4,4’-azobipyridine co-crystals 
 5.4.1 Structural comparison with the CSD 
The Cambridge Structural Database (CSD) was used to compare the bond distances, i.e. 
O···N and X···N (X=I, Br) obtained in our crystal structures with those found in the literature.  
We did a CSD search on O···N and X···N intermolecular bond distances between pyridine type 
compounds and aromatic hydrogen bond donors and halogen bond donors respectively (Fig 5.21 
and 5.22). The comparison of bond distances is listed in Table 5.5.  
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Figure 5.21 Histogram displaying a) acid-pyridine b) phenol-pyridine and c) oxime-
pyridine O...N intermolecular bond distances from the CSD 
 
Figure 5.22 Histogram displaying X...N bond distances a) I...N and b) Br...N from the CSD 
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Table 5.5 Bond distance comparison 
Intermolecular bond Number of hits in CSD Distance(Å)  
(CSD) 
Distance(Å) 
(Experimental) 
 
O···N (acid-py) 456 2.63(6) 2.60 
O···N (phenol-py) 482 2.74(8) 2.62 
O···N (oxime-py) 10 2.70(4) 2.71 
I···N 157 2.880 (130) 2.86 
Br···N 41 3.031 (20) 2.90 
 
Based on data from the CSD and from our experiments, it is clear that the O···N bond 
distance in acid-py interaction is much shorter than in phenol-py and oxime-py (Table 5.5). The 
average O···N bond distance in phenol-py and oxime-py interactions are very similar. However, 
it may not be possible to make inferences about the „strengths‟ of the different interactions and 
rank them purely based on the D···A bond distances due to other extraneous factors that 
contribute to the arrangement of molecules in the crystal lattice. 
The I···N bond distance is shorter than the Br···N bond distance and is consistent in both 
the literature as well as our crystal structures (Table 5.5). From the experimental values, the 
X···N bond distances correspond to a contraction of 18.3% and 10.6% in I···N and Br···N 
compared to the van der Waals radii of I···N and Br···N, respectively. An increased contraction 
is indicative of a stronger halogen bond (I···N).
6
 Iodine is thus a better halogen bond donor than 
bromine, which is also in good agreement with the electrostatic argument which shows that 
iodine with a more positive σ hole is a better donor than bromine. To support this further, iodine 
engages in a primary halogen bonded interaction with the most basic nitrogen atom in 4/6 cases, 
while bromine does so only in 2/6 instances. Bromine is involved in secondary interactions with 
auxiliary acceptors like „O‟ or azo „N‟ 4/6 times, while iodine interacts only 2/6 times. All these 
factors suggest that iodine is a more potent donor than bromine. 
 5.4.2 Structural consistency 
 5.4.2.1 Co-crystals of 3,3’-azopyridine 
The crystal structures of 3,3’-azpy with six bi-functional donors indicate that in 5/6 
structures the primary interaction occurs between a hydrogen bond donor and pyridine nitrogen 
(Table 5.4 and Fig 5.20). The halogen atoms acts as XB donors and serve to link primary motifs 
into two dimensions via secondary interactions with other potential acceptors. The resulting 
architecture is 2-D planar sheets.  In all five cases hydrogen bond “wins” over the halogen bond, 
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i.e. HB > XB. The only outlier is 3,3’-azpy:Ox-I, where the iodine atom “wins” over the oxime 
hydrogen, i.e. XB > HB.  
 5.4.2.2 Co-crystals of 4,4’-azopyridine 
In 4,4’-azpy co-crystals, very different structural assemblies are observed. Both types of 
donors equally contribute in the structure directing assembly process forming 1-D chains (5/6) 
(HB = XB) (Table 5.4 and Figure 5.20). The only outlier in this series is 4,4’-azpy:Ox-Br, 
where hydrogen atom wins over bromine, while bromine interacts with azo nitrogen atoms (1/6) 
(HB > XB).  
In all the co-crystal combinations there were several potential donors (acid, phenol, 
oxime, iodine and bromine) and acceptors („N‟py, „N‟azo, „O‟carbonyl and „O‟hydroxyl). In such a 
complex system, it was perfectly reasonable to expect some degree of structural „chaos‟. 
However, we note a high degree of structural fidelity in the binding pattern within two classes of 
acceptors (Table 5.4 and Figure 5.20).  
 5.4.3 Plausible explanations for the observed trend 
There is a clear binding preference observed in the two classes of azopyridine with the 
same donor probe. In 3,3’-azpy co-crystals, hydrogen bonding dominates over halogen bonding, 
whereas in 4,4’-azpy both interactions occur concomitantly. This binding preference cannot be 
explained purely based on an electrostatic argument of the acceptors, since the charges on the 
pyridine nitrogen in the two acceptors differ only by a couple of kJ mol
-1 
(Ch 4, Fig 4.4). This 
difference is not significant enough to have an influence on the binding preference between the 
two types of donor atoms. In order to seek an explanation for the observed binding pattern, we 
have explored the electrostatic potentials on donor molecules as well as examined the packing 
co-efficient values and melting point trends in the two classes of azopyridine co-crystals. 
 5.4.3.1 Electrostatic surface potential calculations of donor probes 
Geometry optimizations were carried out followed by molecular electrostatic potential 
surface (MEPS) calculations on the six bi-functional donors using Spartan, 2010 (Wavefunction, 
Inc. Irvine, CA). Both semi-empirical and DFT (B3LYP, 6-31G++G** basis set) methods were 
used (Table 5.6).   
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Table 5.6 Electrostatic surface potentials expressed as charges in kJ mol
-1
 
 COOH-I COOH-Br OH-I OH-Br Ox-I Ox-Br 
 H I H Br H I H Br H I H Br 
PM3 144 222 144 160 156 202 163 152 134 204 135 147 
DFT 296 166 305 142 305 155 314 121 283 153 276 129 
  
Although the numbers obtained for the surface potentials using PM3 and DFT methods 
were different, the trend observed was the same, i.e. the positive potentials on the donors 
decreased in the following order; phenol-H > acid-H > ox-H. This trend is also consistent with 
the previously reported hydrogen-bond parameters for common functional groups.
16
 Another 
inference that can be made based on the surface calculations is that iodine has a more positive σ 
potential than bromine, which makes it a better halogen bond donor.  The MEPS however fail to 
provide an additional insight into why hydrogen bonds are formed primarily in 3,3’-azpy co-
crystals while hydrogen and halogen bonds are preferred in 4,4’-azpy class of co-crystals. 
 5.4.3.2 Packing co-efficients and melting points of co-crystals 
The packing co-efficient values and melting points of co-crystals are listed in Tables 5.7 
and 5.8 respectively. Packing co-efficients were calculated using Olex2 v1.2 software. 
Table 5.7 Packing co-efficient and melting points in 3,3'-azpy co-crystals 
 COOH-I COOH-Br OH-I OH-Br Ox-I Ox-Br 
Packing co-efficient % 74 69 68 71 69 69 
Melting points °C 182-183 155-157 125-127 170-173 145-148 105-108 
 
Table 5.8 Packing co-efficient and melting points in 4,4'-azpy co-crystals 
 COOH-I COOH-Br OH-I OH-Br Ox-I Ox-Br 
Packing co-efficient % 74 76 67 69 66 67 
Melting points °C 220-222 190-191 163-165 133-136 115-116 125-126 
 
The packing co-efficient values in all 12 co-crystals range from 66-74%. The values 
across the two classes with the same donors are very similar. There is no observable deviation in 
the packing co-efficient values of the outliers in each series when compared to the other five co-
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crystals in the same series. Thus packing co-efficient values are ineffective in providing a 
plausible reason for the observed structural behavior. 
Along similar lines, melting points of the co-crystals also show no trend within each 
series. The melting points of the outliers (3,3’-azpy:Ox-I and 4,4’-azpy:Ox-Br) do not display 
noticeable difference from the other co-crystal in each series. Thus melting points do not provide 
an insight into the observed binding preference within each class of co-crystals. 
 5.4.3.3 Geometric bias on the acceptor molecule  
An investigation of the electrostatic potentials, packing co-efficients and melting point 
trends did not provide any plausible explanation for the observed structural behavior in the two 
classes of co-crystals. We therefore propose to rationalize the observed „synthon crossover‟ 
event based on the differences in the binding site orientation of the two acceptor molecules (Fig 
5.4).  
In 3,3‟-azopyridine the binding sites have an anti-parallel orientation with respect to each 
other (Fig 5.4). The six donor molecules under consideration also have their two donor sites at a 
1-4 position, i.e. linear (Fig 5.4). Considering the geometric non-complementarity between the 
two interacting species, it is conceivable that for 1-D chain formation, molecules need to be 
forcefully brought into close proximity at suitable angles. This would increase the energy of the 
system thus compromising on its stability. On the other hand, the molecules complement 
themselves well enough to form discrete trimer which is less challenging and easy on the system. 
The trimers can then be connected into 2-D sheets via secondary interactions. Under such 
conditions, a hydrogen atom (which is considered to be slightly more competitive than a halogen 
atom as a donor) binds to the best acceptor forming stable trimers. The halogen atoms are then 
used to connect individual trimers via interactions with secondary acceptors into extended 
architectures. 
4,4‟-azopyridine has the binding sites oriented linear with respect to each other (Fig 5.4).  
The geometries of the acceptors and donors complement each other very well to favor easy 
formation of linear 1-D chains without any energy expense. Under such conditions, there is a 
50:50 chance that the pyridine nitrogen will pick up both, hydrogen as well as halogen atom on 
either side to form 1-D chains which is what we observe in five out of six co-crystals. 
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 5.5 Conclusion 
We have synthesized twelve co-crystals of 3,3‟-and 4,4‟-azopyridine with six bi-
functional donors each and demonstrated the following; 
1) Structural consistency is obtained in the crystal structures within each class, i.e. in 
3,3’-azpy co-crystals trimers are formed by hydrogen bonds followed by their 
extension into 2-D sheets via secondary halogen bond interactions (5/6 HB > XB) and 
in 4,4’-azpy co-crystals 1-D chains are formed via both hydrogen as well as halogen 
bonds (5/6 HB = XB).  
2) Both halogen bond and hydrogen bond donors participate in primary interactions and 
the choice of the acceptor for either of them is governed by the geometric bias on 
acceptor sites. 
3) Auxillary acceptors such as carbonyl „O‟, hydroxyl „O‟ and azo „N‟ all participate in 
secondary interactions in extending the lattice.  
Since hydrogen and halogen bond donors are comparable and competitive in a given 
system, a larger number of data needs to be generated and analyzed in order to establish a 
reliable ranking between the two. A deeper investigation of similar experiments carried out using 
3,3‟-and 4,4‟-stilbene derivatives (analogous to 3,3‟-and 4,4‟- azopyridines) along with the six 
bifunctional donors will provide us with a larger dataset and further evidences to support our 
findings. Since the stilbenes are analogous to azobenzenes, we expect similar structural outcomes 
in the two classes of co-crystals as observed in the case of 3,3‟-and 4,4‟-azopyridines. 
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Chapter-6 Using co-crystallization to alter physical properties of 
agrochemical pesticides 
 6.1 Introduction 
As the demand for food globally increases with increasing population, the resources 
needed for meeting the increasing food demand remain limited. Agrochemicals provide a means 
of increasing the productivity of farming by producing a wide range of chemicals which protect 
the crops from damage by pests and weeds, thus resulting in better produce.
1
 A recent poll about 
a farmer‟s perception of pesticides clearly indicates that pesticides play an important role in crop 
production as they provide us with good quality products in higher yields by killing and 
controlling the pests that infest the crops (Fig 6.1).
2
  
 
            Figure 6.1 Result of a recent poll about farmer's perception of pesticides
2 
 
Agrochemicals are typically applied to the crops in the form of a solid (dusts, powders or 
granules) or a liquid (suspension) formulation.
3
 For the purpose of effective solid formulation, it 
is important that certain physical characteristic such as high melting point and crystallinity of the 
sample is maintained. However, most of the agrochemical actives are amorphous and also have 
low melting points, resulting in inefficient processing, formulation and application of the active.
4
 
Likewise, in a liquid formulation, a problem could arise from Ostwald ripening  (tendency of 
crystalline materials to form large crystals due to ageing).
5
 In addition, polymorphic 
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transformation of the active is another area of concern due their potential to switch between 
different forms under ambient storage conditions resulting in complications during storage, 
application and formulation.
6
 All these issues related with agrochemical actives (Fig 6.2) suggest 
the need for modification of the physico-chemical properties of the actives that influence the 
morphology and behavior of the actives, resulting in better end use properties.  
 
Figure 6.2 Problems with agrochemical actives
3,4,5,6
 
 
Co-crystallization can be used as a reliable technique to form alternative solid forms of 
agrochemical actives which display,
6
 
i) Improved melting points 
ii) Increased solubility  
iii) Decreased solubility 
iv) Improved storage and formulation stability 
v) Modified crystal morphology and so on.  
 
In order to demonstrate the effectiveness of co-crystals in generating new crystalline solid 
forms of the actives with improved physical properties, we have synthesized co-crystals of two 
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agrochemical pesticides, namely, cyprodinil and terbuthylazine with co-formers such as succinic, 
adipic, suberic, sebacic and dodecandioic acid (Fig 6.3). Since the actives have amino-pyridine 
based binding sites, stable supramolecular synthons via hydrogen bonds can be formed with the 
diacids (as seen previously in section 2.3.1). For the purpose of structural characterization, single 
crystal structures of all co-crystal combinations were analyzed. Furthermore, changes in 
solubility, melting point behavior and hygroscopicity as a result of co-crystallization will also be 
explored for cyprodinil co-crystals. 
 
Figure 6.3 a) cyprodinil b) terbuthylazine and c) series of even-chain diacids 
 
The goals of our study are to: 
1) Explore the potential of cyprodinil and terbuthylazine in forming co-crystals with 
diacids. 
2) Test the potential of co-crystallization in tuning the solubility and melting point of the 
agrochemicals. 
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3) Test the hygroscopicity of the co-crystals and compare them with the parent active.  
 6.2 Experimental 
Cyprodinil and terbuthylazine were acquired from Syngenta and used without further 
purification. The dicarboxylic acids were purchased from Sigma Aldrich and used without 
further purification. Melting points were recorded on a Fisher- Johns melting point apparatus and 
were corrected for using a calibration curve (Fig 6.16). Infrared spectroscopy (IR) was 
performed on a Nicolet 380 FT-IR. Humidity measurements were carried out in a sealed vessel 
that was saturated with appropriate salt solutions. 
 6.2.1 Synthesis of co-crystals 
The acid and the active were dissolved in a 1:1 ratio in methanol and the co-crystals were 
synthesized using slow evaporation method. Good quality crystals were obtained within few 
days for all combinations with an exception of Ter:AA and were submitted for single crystal 
analysis. The melting points of the co-crystals obtained by solvothermal synthesis are listed in 
Table 6.1.  
Table 6.1 List of co-crystals of Cyprodinil and Terbuthylazine 
Actives Acids (co-formers) Abbreviation Melting point (°C) 
 
 
   Cyprodinil 
Succinic acid Cyp:SA 128 
Adipic acid Cyp:AA 120 
Suberic acid Cyp:SuA 110 
Sebacic acid Cyp:SeA 101 
Dodecandioic acid Cyp:DDDA 119 
  
 
 
Terbuthylazine 
Succinic acid Ter:SA 184 
Adipic acid Ter:AA 143 
Suberic acid Ter:SuA 153 
Sebacic acid Ter:SeA 168 
Dodecandioic acid Ter:DDDA 165 
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 6.2.2 Preparation of co-crystals for solubility measurements 
Co-crystals of cyprodinil with the even chain diacids succinic C4, adipic C6, suberic C8. 
sebacic acid C10 and dodecanedioic acid C12 were prepared via a solvothermal method.
7
 
Cyprodinil and the acid were combined in a 1:1 ratio and refluxed in 25ml of methanol. After 40 
min of heating, the resulting solution was cooled to 5° C. The precipitated solid was filtered, 
dried and analyzed using IR spectroscopy to confirm co-crystal formation. The PXRD pattern of 
bulk co-crystal and simulated single crystal pattern was compared to further confirm the 
homogeneity of the bulk sample, an example of which is shown in Figure 6.4 and the others in 
appendix B1-B4. 
 
Figure 6.4 PXRD pattern of Cyp+DDDA bulk (solid red) and simulated pattern (dotted 
blue) 
 6.2.3 Solubility measurements on cyprodinil co-crystals 
In order to determine the equilibrium solubility of cyprodinil, first a stock solution of 
cyprodinil was prepared in distilled water (0.0015g in 100ml) and a calibration curve was 
constructed by measuring the absorbance of a series of dilutions of known concentrations, made 
from the stock solution, Fig 6.5. The equation of line obtained from the calibration curve (y = 
mx) was then used to determine the solution concentrations of the saturated samples at 24, 48 
and 72 hour time intervals. The system reached equilibrium within 48hrs (Fig 6.6). 
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Figure 6.5 Calibration curve for solubility of cyprodinil 
 
                     
Figure 6.6 Cyprodinil system equilibrium curve 
 
In order to determine the solubility of cyprodinil co-crystals, a suspension of the co-
crystal (0.100g) was stirred in 10ml of distilled water in a sealed vial and placed in a water bath 
to maintain constant temperature. After stirring for 48hrs, the remaining solid was filtered. A 1 
ml aliquot of the filtrate was diluted to 10ml using distilled water (dilution factor = 10) and the 
absorbance of cyprodinil at λmax = 268nm was measured using UV-Vis spectroscopy, Shimadzu 
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UV-1650-PC. The absorbance (y) values were used to calculate the corresponding concentrations 
(x) from the equation of line (y=mx) of the calibration curve. The calculated concentration was 
then multiplied by the dilution factor to get the final concentration and thus the solubility of the 
active in the co-crystal form. 
 6.2.4 Hygroscopicity studies on cyprodinil co-crystals 
In order to determine the stability of cyprodinil co-crystals in the presence of atmospheric 
moisture, the co-crystals were subjected to two different humidity conditions, 85% and 43% in a 
closed chamber. The humidity conditions were generated using saturated salts solutions of 
potassium chloride (85%) and potassium carbonate (43%) by dissolving 200g of the salt in 90ml 
of water. The humidity level was tested using a humidity indicator strip. 100mg of co-crystal 
samples were measured in open glass vials which were placed in a closed chamber. The 
chambers were filled up to 1/4
th
 its capacity with saturated salt solutions to generate the desired 
humidity conditions. The water uptake by the samples was measured at different intervals such 
as 1, 3, 5, 7, 14, 21 and 28 days using the following equation
8
, 
Hygroscopicity =                 X 100 
where Wn : weight of sample + vial (at time t), Ws : weight of sample + vial  (t = 0), Wo : 
weight of empty vial.  
X-ray powder diffraction data of the samples were collected at the end of the humidity 
experiments to get information on the final form.  
6.3 Results 
There are two known forms of cyprodinil, form A and form B. From the PXRD data, it is 
clearly evident that the cyprodinil we have used for our experiments is form B (Fig 6.7)
9
. 
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Figure 6.7 PXRD of cyprodinil form B and its simulated pattern 
 6.3.1 Analysis of the single crystal structures of cyprodinil co-crystals  
The crystal structure of cyprodinil displays a dimer formed via hydrogen bond 
interactions between the amino pyridine sites (Fig 6.8).
9 
The second nitrogen atom on the 
cyprodinil backbone is inactive. 
 
Figure 6.8 Main hydrogen bonds in cyprodinil form B  
 
In the co-crystal of Cyp:SA, Cyp:AA, Cyp:SuA, Cyp:SeA and Cyp:DDDA (Fig 6.9),  
the amino-pyridine dimer interaction between cyprodinil is broken and is replaced by O-H···N 
hydrogen bonds between the acid and amino-pyridine site resulting in trimers. The second 
binding site on cyprodinil remains inactive and does not participate in any hydrogen bond. All 
crystal structures belong to a monoclinic space group, with an exception of Cyp:SuA which 
belongs to triclinic space group. 
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Figure 6.9 Trimers formed in the co-crystals of a) Cyp:SA b) Cyp:AA c) Cyp:SuA d) 
Cyp:SeA and e) Cyp:DDDA via O-H···N hydrogen bonds between acid and amino-pyridine 
binding sites 
 6.3.2 Analysis of single crystal structures of terbuthylazine co-crystals 
The co-crystals of terbuthylazine with succinic, suberic, sebacic and dodecandioic acid 
display infinite 1-D chains form via two types of interactions, i.e. a heteromeric hydrogen bonds  
between the acid (COOH) and amino-pyridine (N-NH) group and a homomeric interaction 
between the amino-pyridine groups of two terbuthylazine moieties (Fig 6.10). 
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Figure 6.10 1-D chains formed in co-crystals of terbuthylazine with a) succinic acid, b) 
suberic acid, c) sebacic acid and d) dodecanedioic acid 
 6.3.3 Tailoring aqueous solubility of cyprodinil 
Based on our results, the solubility of cyprodinil is 0.0647(13) g/L. The solubilities of the 
co-crystals were found to be different from the parent compound, Figure 6.11. In the co-crystal 
of cyprodinil with succinic acid (C4), a 3.3 fold increase in the solubility is observed. As we 
move from C4 to longer chain diacids, the solubility decreases along the direction of increasing 
carbon chain length. The co-crystal of cyprodinil with the longest chain diacid, i.e. dodecandioic 
acid (C12), shows a 0.47 fold decrease in solubility compared to the parent active itself.  
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Figure 6.11 Solubility profile of cyprodinil co-crystals 
 6.3.4 Hygroscopicity studies 
In the humidity experiments of cyprodinil co-crystals, there was no significant uptake of 
water at either 85% or 43% relative humidity conditions, indicating that the co-crystals are 
relatively stable to humidity stress over a period of 1 month (Fig 6.12 and 6.13). A minimal 
uptake (< 1.5 % water) at 85% humidity (Fig 6.12) and < 2.5 % water at 43% humidity (Fig 
6.13) is observed.  The observed differences can be attributed to the physisorption of water on 
the surface of the solid-samples.  
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Figure 6.12 Water uptake measured as a function of days in cyprodinil and its co-crystals 
at 85% relative humidity 
 
 
Figure 6.13 Water uptake measured as a function of days in cyprodinil and its co-crystals 
at 43% relative humidity 
PXRD measurements of all co-crystal samples before and after the completion of 
hygroscopicity studies indicate no change in form of the solid-sample (Fig 6.14-6.15 and 
appendix B5, B6, B7). This indicates that the co-crystals remain stable under normal processing 
and storage conditions, which is of significance during a pesticide development process.  
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Figure 6.14 PXRD pattern of Cyp:SuA (red dotted) before hygroscopicity measurements 
and Cyp:SuA 84% (green) after 1month of hygroscopicity measurement 
 
     
Figure 6.15 PXRD pattern of Cyp:DDDA (purple solid) before hygroscopicity 
measurements and Cyp:SA 84% (orange dotted) after 1month of hygroscopicity 
measurement 
 6.3.5 Melting point variations in cyprodinil and terbuthylazine co-crystals 
Melting point is an important physical property for effective handling, processing, 
formulation and storage of pesticides. From this point of view a higher thermal stability for 
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compounds is mostly desirable. In order to record the melting points of co-crystals a calibration 
curve (expected vs. recorded melting points) was constructed for few standard samples whose 
melting points were accurately known (Fig 6.16).  
 
 
Figure 6.16 Calibration curve for melting point 
The calibration curve equation was then used to calculate the expected melting points of 
co-crystals from their corresponding recorded melting points. It was observed that while 
cyprodinil had a melting point of 76 °C, the co-crystals of cyprodinil showed an increase in the 
melting point, Fig 6.17. 
 
 
Figure 6.17 Melting point profile of cyprodinil and its co-crystals 
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Likewise, the melting points of terbuthylazine co-crystals were also calculated using the 
calibration curve (Fig 6.18) 
 
Figure 6.18 Melting point profile of terbuthylazine and its co-crystals 
 6.4 Discussion 
 6.4.1 Co-crystals of cyprodinil and terbuthylazine 
Molecular electrostatic surface potential calculations performed on cyprodinil and 
terbuthylazine using semi-empirical PM3 theory suggested the following, 
1) In cyprodinil, N(1)  has a surface potential charge of -267 kJ/mol and is free from 
steric hindrance whereas N(2) is sterically hindered by the phenyl group and is not a 
potential acceptor site (Fig 6.19a). 
2) In terbuthylazine, N(1) and N(2) have surface charges of -303 and -294 kJ/mol 
respectively. The third nitrogen is sterically very hindered by the bulky isopropyl 
group and thus is not a potential site for hydrogen bonding (Fig 6.19b). 
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Figure 6.19 Surface potential charges in a) cyprodinil and b) terbuthylazine 
Based on the data obtained from our crystal structures (Fig 6.9 and 6.10), the potential of 
cyprodinil and terbuthylazine in forming co-crystals is clearly evident, i.e. 100% co-
crystallization. More importantly, all the crystal structures obtained support the theoretical 
calculations which confirm the inactivity of nitrogen atoms N(2) and N(3) in cyprodinil and 
terbuthylazine, respectively due to steric hindrance which makes them inaccessible to the 
approaching hydrogen-bond donors. 
 6.4.2 Correlating aqueous solubility of co-crystals with co-former solubility 
In chapter 3 it was established that the solubility of a given co-crystal is proportional to 
its corresponding co-former solubility. In parallel to this observation, a very good correlation 
was also found between cyprodinil co-crystal and their corresponding co-formers (Fig 6.20). As 
seen before, the solubilities of cyprodinil co-crystals decreased as a function of the increasing 
hydrophobicity of the co-formers.  
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Figure 6.20 Relationship between co-crystal and co-former solubility in cyprodinil co-
crystals 
 6.4.3 Melting point as a function of carbon chain length 
In the solid state, diacids form 1-D infinite chains via hydrogen-bond interactions 
between terminal carboxy groups. This structural consistency is maintained throughout the series 
from short to long chain diacids. It is well known that the melting point in a series of diacids 
decreases with an increase in the number of methylene carbon atoms in the diacid backbone.
10
 
Similar observations were made in multi-component systems, where the observed structural 
consistency among 1-D infinite chains in a co-crystal (between a diacid and a ditopic acceptor) 
could be translated into decreasing melting points with increasing carbon atoms of diacid.
11
  
In our cyprodinil system, the primary building block in all co-crystals is a trimer between 
one acid molecule and two cyprodinil moieties on either ends of the diacid. The trimers then 
pack within the crystal lattice to form the most stable arrangement. The co-crystals of cyprodinil 
with diacids C4 to C10 display a decreasing trend in melting points with increasing diacid chain 
length, which is consistent with similar results observed in the literature (Fig 6.21, top). 
However, the co-crystal with C12 does not follow the trend, but instead displays a higher melting 
point than the others in the series (Fig 6.21, bottom). This indicates that in the co-crystal of 
cyprodinil with longer chain diacid (C12), the weaker van der Waal forces play a more 
significant role, attributed to the longer aliphatic chain of carbon atoms.  
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Figure 6.21 Correlation between melting point of co-crystals and carbon chain length C4-
C10 (top) and C4-C12 (bottom) 
In the crystal structure of terbuthylazine that we obtained via slow evaporation, 1-D 
chains are formed between neighboring terbuthylazine moieties via two intermolecular N-
H···N(amino-pyridine) homomeric hydrogen bonds. The 1-D chains are further stabilized by weak 
interactions of chlorine with C-H of the ter-butyl group on neighboring terbuthylazine. The 1-D 
chains further extend into 2-D network via interchain C-H···Cl halogen bonding interactions 
between the chlorine atom on one chain and tert-butyl group on the neighboring chain (Fig 6.22). 
Due to these primary hydrogen bond interactions accompanied by secondary halogen bond 
interactions, Terbuthylazine displays a higher melting point than its co-crystals, with an 
exception of Ter:SA (Fig 6.18). 
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Figure 6.22 Crystal arrangement in terbuthylazine 
In the co-crystals, one of the homo-dimer interactions is broken and replaced by an acid-
amino-pyridine interaction, while the second homo-dimer interaction is maintained. A notable 
feature of the co-crystals is the absence of any C-H···Cl halogen bond interactions (Fig 6.10). 
This could explain why co-crystals of terbuthylazine have lower melting points than the parent 
active.  
Among the co-crystals, Ter:SA, Ter:AA and Ter SuA display a decreasing trend in their 
melting points with increasing carbon chain length. However, the melting points of Ter:SeA and 
Ter:DDDA are higher and do not follow the decreasing trend. Since the primary mode of 
interactions in all co-crystals is the same (Fig 6.10) forming 1-D chains, the difference in melting 
point could not be explained purely based on their primary interactions in their crystal structures. 
A closer investigation of the densities, packing co-efficients and secondary weaker interactions 
in the crystal structures was performed in order to find a plausible explanation for the observed 
deviation from the melting point behavior. 
 6.4.1 Density and packing co-efficients of terbuthylazine co-crystals 
Table 6.2 lists the values of densities and packing co-efficients (calculated using Olex2 
v1.2 software) of co-crystals of terbuthylazine with succinic, suberic, sebacic and dodecanedioic 
acid. The values of both density and packing co-efficient of the co-crystals decrease from 
succinic to dodecanedioic acid. This however does not explain the observed deviation in thermal 
properties of Ter:SeA and Ter:DDDA co-crystal.  
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Table 6.2 Values of density and packing co-efficient in terbuthylazine co-crystals 
 Ter Ter:SA Ter:SuA Ter:SeA Ter:DDDA 
Density 1.287 1.288 1.260 1.217 1.195 
Packing co-efficient % 59 60 60 59 59 
 
 6.4.2 Investigating secondary interactions in terbuthylazine co-crystals 
While primary interactions direct the crystal formation, weaker secondary interactions 
play a very important role in stabilizing the overall crystal structure. We examined the secondary  
interactions in crystals structures of terbuthylazine co-crystals. The 1-D individual chains extend 
into two dimensional network via secondary C-H(acid)···Π interactions in all four co-crystals (Fig 
6.23). In Ter:SeA and Ter:DDDA co-crystal, the aliphatic backbone of neighboring 1-D chains 
are aligned in close proximity (Fig 6.23 c and d). Thus there is an additional hydrophobic 
interaction present between the aliphatic chains of the diacids. 
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Figure 6.23 Packing of 1-D chains in co-crystals of terbuthylazine with a) succinic acid, b) 
suberic acid, c) sebacic acid and d) dodecanedioic acid 
 
In addition to the hydrophobic interactions, in Ter:SeA, interactions are observed 
between the tert-butyl groups of terbuthylazine (Fig 6.24), while in Ter:DDDA, the tert-butyl 
group interacts with hydroxyl oxygen atom of the acid (Fig 6.25). All these supplementary 
interactions provide additional stability to the co-crystals and thus explain the increased melting 
point observed in Ter:SeA and Ter:DDDA co-crystals. 
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Figure 6.24 Extended architecture in Ter:SeA displaying tert-butyl group interactions 
 
 
Figure 6.25 Extended architecture in Ter:DDDA with tert-butyl groups interacting with 
hydroxyl oxygen atoms of the acid 
 6.5 Conclusion 
In conclusion, we have synthesized co-crystals of commercial pesticides, cyprodinil and 
terbuthylazine with even chain dicarboxylic acids and analyzed their single crystal structures and 
other physical properties. Bases on our results we can conclude the following; 
1) Both cyprodinil and terbuthylazine show the potential to form co-crystals with a 
series of diacids with 100% supramolecular yield.  
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2) The co-crystals display melting points different from the parent active. 
3) In cyprodinil co-crystals, we could alter the solubility of the active using co-
crystallization and a very good correlation between the co-crystal solubility and co-
former solubility was observed.  
4) No appreciable change in hygroscopicity was observed at 84% and 43% relative 
humidity conditions for cyprodinil co-crystals. The PXRD patterns collected at the 
end of humidity experiments indicate no degradation or change in form of the solid 
samples.  
Our experiments thus prove the potential of crystal engineering in altering physical 
properties of agrochemical actives in a predictable and desirable manner.  
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Appendix A – 
1
H NMR  
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Appendix A 1 
1
H NMR of 3N 
 
 
Appendix A 2 
1
H NMR of 4N 
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Appendix A 3 
1H NMR of 3,3’-azopyridine 
 
 
Appendix A 4 
1H NMR of 4,4’-azopyridine 
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Appendix B - PXRD patterns 
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Appendix B 1 PXRD pattern of Cyp:SA co-crystal 
 
           
Appendix B 2 PXRD pattern of Cyp:AA co-crystal 
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Appendix B 3 PXRD pattern of Cyp:SuA co-crystal 
 
        
Appendix B 4 PXRD pattern of Cyp:SeA co-crystal 
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Appendix B 5 PXRD pattern of Cyp:SA co-crystal after humidity experiment 
    
      
Appendix B 6 PXRD pattern of Cyp:AA after humidity experiment 
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Appendix B 7 PXRD pattern of Cyp:SeA co-crystal after humidity experiment 
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